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Abstract 
 
Dynamin-related protein 1 (Drp1) is a GTPase of the dynamin superfamily that 
catalyzes mitochondrial fission in the cell. Cytosolic Drp1 is recruited to mitochondria by 
receptors anchored to the outer mitochondrial membrane. Once there, Drp1 assembles 
into a complex around the mitochondrial circumference to drive division via a GTP-
dependent constriction process. The four known receptors of Drp1 are Fis1, Mff, MiD51, 
and MiD49, but stable interactions between Drp1 and these proteins have not been 
established. In addition, though mounting evidence suggests these receptors have non-
redundant roles in their interaction with Drp1, mechanistic details explaining these 
distinctions are lacking. Here we address these questions, and show that the Insert B 
domain of Drp1 inhibits its interaction with Mff. Removal of this domain stabilizes a 
complex of Drp1 and Mff in vitro. In addition, we show that Drp1 oligomerization is a 
requirement for Mff recruitment, but not for MiD51 or MiD49-mediated recruitment. 
Together the results suggest a model in which Drp1 recruitment to mitochondria is 
regulated by the oligomeric state of Drp1, such that Mff, MiD51, and MiD49 recruit 
different subpopulations of Drp1 from the cytosol.  
With this model as a framework, we analyze the effect that a Drp1 R403C mutant, 
identified in several human patients presenting with encephalopathy and refractory 
epilepsy, has on mitochondrial morphology in cultured cells. We find that the loss of 
Drp1 oligomerization in these mutants impedes its ability to be recruited by Mff, leading 
to abnormal elongation of the mitochondrial population.  
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Chapter 1 
 
 
Introduction 
 
Discovery of mitochondrial dynamics 
Mitochondria are organelles in the cell that perform a variety of duties required 
for proper cell function. They generate ATP through oxidative phosphorylation, regulate 
a number of metabolic pathways, synthesize fatty acids, heme and iron-sulfur clusters, 
store and release calcium ions, activate apoptosis, and mediate innate immune response 
signaling (Mitchell, 1961; Scheffler, 2002; Ajioka et al., 2006; Wang and Youle, 2009; 
Hiltunen et al., 2010; West et al., 2011; Rizzuto et al., 2012; Rouault, 2012). The number 
of individual mitochondria per mammalian cell is estimated to be anywhere from 102 to 
103, with each containing their own genome with dedicated replication, transcription, and 
translation machinery (Sinclair and Stevens, 1966; Robin and Wong, 1988; Clayton, 
1991; Taanman, 1999). Individually, the organelle is organized into a double membrane 
layer, with an outer membrane encasing an inner membrane layer, separated by an 
intermembrane space. The inner membrane, embedded with the electron transport chain, 
is organized into folds called cristae that involute from junctions into the central matrix 
compartment, creating a wrinkled appearance (Daems and Wisse, 1966; Mannella et al., 
1994). Early electron images of mitochondria show a static portrait of mitochondria as 
bean-shaped (Palade, 1953; Sjostrand, 1953). Advances in live-imaging microscopy and 
visualization tools introduced a more dynamic portrayal of mitochondria, revealing a 
highly mobile population of spaghetti-like tubules with varied lengths (Bereiter-Hahn and 
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Voth, 1994; Nunnari et al., 1997). In cultured cells, such as mouse embryonic fibroblasts, 
individual tubules could be observed constantly moving and jiggling along invisible 
microtubule tracks, undergoing multiple fission events, in which a single tubule divides 
into two along the short or transverse axis, and fusion events, in which two tubules meet 
at end junctions to merge into one (Chen and Chan, 2004). These observations, and the 
discovery of developmentally essential factors controlling the process, launched the 
currently two decades worth of research in the field now called mitochondrial dynamics 
(Chan, 2006b, a).  
 
Initial identification of essential factors for fission and fusion 
Genetic studies in flies, yeast, and worms laid the early groundwork in 
understanding mitochondrial dynamics, identifying the factors required for the fission 
and fusion events. The first mitochondrial fusion protein discovered was fuzzy onions 
(Fzo), named for the fuzzy onion-like appearance of unfused mitochondria in the 
spermatids of Drosophila fzo mutants. Homologs in yeast (Fzo1p), mice, and humans 
(Mfn1 and Mfn2 for mitofusin 1 and mitofusin 2, respectively) were identified thereafter, 
with mutants harboring loss-of-function mutations in the genes of these proteins 
exhibiting fragmented mitochondria from reduction of mitochondrial fusion (Hermann et 
al., 1998; Rapaport et al., 1998; Santel and Fuller, 2001; Chen et al., 2003; Eura et al., 
2003). These proteins, which came to be called mitofusins, localize to the outer 
mitochondrial membrane of mitochondria, and are essentiaal for the fusion of this outer 
layer (Hermann et al., 1998; Rapaport et al., 1998; Rojo et al., 2002). Inner membrane 
fusion was found to be mediated by mitochondrial genome maintenance 1 (Mgm1p) in 
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yeast, and optic atrophy type 1 (Opa1) in mammals (Olichon et al., 2002; Satoh et al., 
2003; Wong et al., 2003; Meeusen et al., 2006). In mammalian cells devoid of Opa1, 
outer membrane fusion, but not inner membrane fusion, is observed, suggesting complete 
full mitochondrial fusion proceeds in a sequential manner, first by mitofusin-mediated 
outer membrane fusion followed by Opa1-driven inner membrane fusion (Malka et al., 
2005; Song et al., 2009). 
Work in yeast and C. elegans identified the yeast DyNaMin-related 1 (Dnm1) 
protein and worm dynamin-related protein 1 (DRP-1) as the factor required for 
mitochondrial fission (Bleazard et al., 1999; Labrousse et al., 1999; Sesaki and Jensen, 
1999). Mutations in the yeast Dnm1 and C. elegans DRP-1 were shown to block fission, 
resulting in highly elongated and networked mitochondria (Bleazard et al., 1999; Sesaki 
and Jensen, 1999). Immuno-electron microscopy and live-imaging microscopy studies 
localized the proteins to puncta on mitochondria, and overexpression of the proteins 
resulted in fragmented mitochondria (Bleazard et al., 1999; Labrousse et al., 1999). Live-
imaging studies with a green fluorescent protein (GFP) fusion of the mammalian 
homolog, dynamin-related protein 1 (Drp1), similarly showed a punctate localization to 
the mitochondria surface, and examination of dominant-negative Drp1 mutants revealed 
highly elongated mitochondria in cultured cells (Smirnova et al., 1998; Smirnova et al., 
2001). Altogether, these studies of Drp1, mitofusins, and Opa1 established a “dual 
control” model of mitochondrial dynamics, in which the overall morphology of the 
mitochondrial population in a cell is determined by the opposing action of fission by 
Drp1 and fusion by Mfn1/2 and Opa1 (Detmer and Chan, 2007). Knockout mice studies 
clearly demonstrate that this balance is critical for organismal development, as loss of any 
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one of these major factors (Mfn1, Mfn2, Opa1, Drp1) leads to embryonic lethality (Chen 
et al., 2003; Davies et al., 2007; Ishihara et al., 2009; Wakabayashi et al., 2009). In 
addition, disease-causing variants of each of these factors have been described in humans 
(Chen and Chan, 2009). 
 
Dynamins regulate mitochondrial fission and fusion 
Mfn1, Mfn2, Opa1, and Drp1 belong to a family of large guanosine triphosphate 
hydrolases (GTPases) called dynamins, molecular machines that that are specialized for 
mediating membrane remodeling in the cell (Praefcke and McMahon, 2004). From a 
physical mechanics perspective, both mitochondrial fission and fusion require, at some 
point, fusion of two separate phospholipid bilayers. This carries a high energetic cost 
(Chernomordik and Kozlov, 2008; Lenz et al., 2009). Dynamins, however, are well-
suited for this challenge, by having several biochemical properties that help to solve this 
problem. Dynamin GTPase activity allows the coupling of nucleotide hydrolysis to 
membrane deformation, providing energy to lower the energetic cost of membrane 
fusion. The ability to bind lipids, and the ability to self-assemble into helical arrays, allow 
dynamins to induce curvature of its membrane substrate and modulate its tension, 
potentially lowering the energy barrier for fission and fusion (Morlot et al., 2012; 
Antonny et al., 2016). Though they have been identified to play specific roles in 
mitochondrial fission and fusion, the exact mechanism of how Mfn1, Mfn2, Opa1, and 
Drp1 carry out those roles is not well understood and is an active area of investigation. 
Since their biochemical properties likely form the basis behind the mechanism, many 
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studies have focused on understanding basic dynamin biochemistry (Antonny et al., 
2016). 
 
Dynamin structure and biochemistry 
 Dynamin, the founding member of the dynamin protein family, was initially 
discovered in 1989 as a 100 kilodalton (kDa), microtubule-associated protein from 
mammalian brain lysates (Shpetner and Vallee, 1989). It was named “dynamin” from the 
Greek word “dynamis” for force or power, because of a dynamic microtubule sliding 
activity observed in vitro that was later found to be misattributed to the molecule. 
Cloning and sequencing of the gene eventually grouped it with a family of large GTP-
binding and hydrolyzing proteins, alongside the mouse antiviral Mx proteins and the 
yeast vacuolar protein sorting factor, VPS1 (Obar et al., 1990). Dynamin was shown to 
be homologous to the product of the Drosophila shibire (Japanese for “limbs going to 
sleep”) gene, the mutants of which exhibit temperature-sensitive paralysis due to defects 
in endocytosis at neuronal synapses (Poodry and Edgar; Chen et al., 1991; van der Bliek 
and Meyerowitz, 1991). Experiments showing the formation of dynamin collars at the 
neck of budding endocytic vesicles established its role in presynaptic vesicle formation, 
and images of its in vitro helical assembly around lipid tubules inspired the current model 
of dynamin as a self-assembling GTPase critical for vesicular membrane scission 
(Koenig and Ikeda, 1989; Hinshaw and Schmid, 1995; Takei et al., 1995).  
Elegant work by several groups has developed a basic picture of dynamin 
behavior. Dynamin can self-assemble into rings and helical spirals in vitro (Hinshaw and 
Schmid, 1995). When added to membrane templates such as liposomes, dynamin can 
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assemble into helical arrays that tubulate the membrane (Hinshaw and Schmid, 1995; 
Marks et al., 2001). Addition of non-hydrolyzable GTP promotes and stabilizes the 
polymer on lipid tubules, and hydrolysis of GTP is required to disassemble and release 
dynamin from the membrane (Marks et al., 2001). Hydrolysis of GTP also leads to 
constriction of the helical polymer, and is required for membrane scission during 
endocytosis (Marks et al., 2001). Exactly how GTP hydrolysis and the resulting 
constriction lead to membrane scission, however, is unclear, and continues to be actively 
investigated (Antonny et al., 2016).  
 Dynamin and its family members share a similar body plan, plus or minus a 
domain or two. At the ‘head’ or N-terminus of most dynamins sits the highly conserved 
GTPase domain (G domain), responsible for binding and hydrolyzing GTP (Faelber et 
al., 2011; Ford et al., 2011; Ferguson and De Camilli, 2012; Antonny et al., 2016). This 
activity translates into a conformational rearrangement at the hinge-like ‘neck’ of 
dynamin, a short three-helical bundle signaling element (BSE) domain adjacent and 
continuous with the G domain (Chappie et al., 2011; Faelber et al., 2011; Ford et al., 
2011). The BSE connects the G domain to the main ‘body’ of dynamin, which consists of 
a cylinder-like, four-helical bundle stalk domain (Faelber et al., 2011; Ford et al., 2011; 
Reubold et al., 2015). Classically referred to as the middle domain, the stalk domain 
mediates the hallmark oligomerization activity of dynamin. The opposite end of the stalk 
domain contains the least conserved region of dynamin, a domain that varies in size and 
function across the different dynamin family members (Strack and Cribbs, 2012). In most 
dynamins, this domain mediates its association with lipids, membrane surfaces, and 
interacting partners (Achiriloaie et al., 1999; Lemmon, 2007).  
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The G domain of dynamin is unique in that it has a lower nucleotide binding 
affinity, and faster basal hydrolysis rate, than the G domains of other GTPases, such as 
those of the Ras family of small GTPases or G-protein coupled receptors (Song and 
Schmid, 2003). Not surprisingly, this property is more similar to that of ATP-driven 
motors such as kinesin, reflecting dynamin’s role as a mechanoenzyme (Antonny et al., 
2016). Moreover, in contrast to the heterotypic associations seen with other GTPases, 
stimulation of GTP hydrolysis in dynamins is catalyzed by the homotypic association of 
via the G domain, similar to the bacterial tRNA modification GTPase MnmE protein or 
eukaryotic signal recognition particle SRP (Gasper et al., 2009; Chappie et al., 2010). 
One crystal structure model of the G domain bound to an unhydrolyzable GTP suggests 
that GTP binding results in a conformational switch at the BSE hinge region, relative to 
crystal structure models of the G domains in an apo or GDP-bound state (Niemann et al., 
2001; Chappie et al., 2011). Together with cryo-electron microscopy (cryo-EM) 
reconstruction studies of dynamin assembled around a lipid tubule, the structures suggest 
an assembly model in which two GTP-bound G domains, from adjacent rungs of a 
dynamin spiral, reach across while in an extended BSE conformational state and dimerize 
with each other to catalyze GTP hydrolysis. Hydrolysis induces the BSE to return to the 
ground state, a movement that delivers a powerstroke that drives constriction of the 
dynamin polymer into a smaller diameter (Chappie et al., 2011). Successive constrictions 
through this powerstroke mechanism is believed to squeeze the membrane tubule until 
membrane scission occurs. 
The crystal structure of the stalk domain of the immunity-related myxovirus 
resistance protein 1 (MxA) provided the first mechanistic insight into how dynamin 
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forms its helical arrays (Arnheiter and Meier, 1990; Gao et al., 2010). The structural 
model revealed a four-helical bundle that forms a stable interaction with another stalk 
through a symmetrical hydrophobic interface. This dimeric unit, typically depicted as a 
cross, interacts with an adjacent dimer to generate a tetrameric species. This occurs 
through a symmetrical hydrophobic interface near the BSE end of the stalk, and an 
asymmetric third interface, composed of poorly resolved loops located in two locations 
along the first helical span. Dynamin self-assembly is achieved by continued iteration at 
these two interfaces, at angles to achieve a helical pitch, to create the higher-order 
oligomeric rings and spirals observed in the electron microscopy studies previously 
mentioned. Mutations introduced into these interface residues in MxA, dynamin, and 
Drp1 result in stable dimers unable to form higher-order oligomers (Faelber et al., 2011; 
Ford et al., 2011; Gao et al., 2011; Frohlich et al., 2013). Supporting this model is the 
crystal structure of a dynamin tetramer that depicts resolved features of the loop 
interactions (Reubold et al., 2015).  
 
Mitochondrial fusion dynamins 
 The mitochondrial outer membrane dynamins, mitofusins Mfn1 and Mfn2, and 
the mitochondrial inner membrane fusion dynamin, Opa1, are unique in that they are 
tethered to their respective membranes (Rojo et al., 2002; Griparic et al., 2004). By 
analogy to the homologous bacterial dynamin-like protein (BDLP), the mitofusins are 
believed to be tethered to the outer membrane via a hydrophobic patch located at the 
variable region located at the tip of the dynamin stalk (Low and Lowe, 2006; Qi et al., 
2016; Cao et al., 2017). Compared to the dynamin, BDLP is different in that its BSE 
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helices are longer and feature a much more acute angle at its junction with the stalk 
domain, creating an overall ‘V’ shape for the molecule (Low and Lowe, 2006). A cryo-
EM reconstruction of BDLP, bound to the unhydrolyzable GTP analog GMPPNP and 
assembled around a lipid tubule, depicts a remarkably different conformation, with BDLP 
adopting a straightened linear configuration, such that the BSE and stalk helices are 
collinear (Low et al., 2009). This suggests that the BDLP conformation is regulated by 
nucleotide binding and lipid association. Recent structures of mammalian mitofusin 
truncations, consisting of just the GTPase and BSE region of the molecule, bear a close 
resemblance to BDLP, suggesting a similar mechanism and overall structure might apply 
(Qi et al., 2016; Cao et al., 2017). Like other dynamins, the mitofusins also seem to be 
regulated by G domain-dimerization interactions, and are proposed to mediate the joining 
of opposing membranes to drive fusion. A tethering step, through an anti-parallel coiled-
coil interaction between the C-terminal helices of two opposing mitofusins, might also 
feature in the fusion mechanism, as suggested by a crystal structure of the coiled-coil 
interaction (Koshiba et al., 2004). How and whether higher-order oligomerizations might 
factor into the fusion process is not known. 
Opa1 localizes to the mitochondrial intermembrane space, and is tethered to the 
inner membrane by a transmembrane domain located N-terminal to the GTPase domain 
(Olichon et al., 2002). Between this transmembrane domain and the start of the dynamin-
homologous half of the protein lies a relatively unstructured region, save for one or two 
predicted coiled-coil domains. This intermediary stretch contains two cleavage sites for 
protease-catalyzed release of Opa1 from the membrane into the intermembrane space. 
Cleavage results in a dual population of soluble ‘short’ form Opa1 in the intermembrane 
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space together with an uncleaved ‘long’ form tethered to the inner membrane (Ishihara et 
al., 2006; Song et al., 2007). It has been accepted that the long form is required for fusion 
of the inner membrane, but no agreement has been reached over the role of the short form 
(Song et al., 2007; Anand et al., 2014). In vitro, the behavior of short form Opa1 
resembles that of dynamin in its ability to tubulate lipid templates, but other properties, 
such as its assembly mechanism and mode of higher-order oligomerization, might differ, 
as suggested by 2-D electron microscopy reconstructions of mgm1p that hint at trimeric 
interactions and our own unpublished observations that hint at a much weaker stalk-stalk 
interaction compared to dynamin or Drp1 (DeVay et al., 2009; Ban et al., 2010).  
 
The mitochondrial fission dynamin, Drp1 
 The current working model of mitochondrial fission describes a coordinated series 
of mitochondrial constriction events beginning with an initial constriction mediated by 
circumscribing ER tubules, followed by the recruitment of the mitochondrial dynamin 
Drp1 to the mitochondrial surface to further the constriction and ultimately split the 
mitochondria (van der Bliek et al., 2013). In mammalian cells, assistance from actin 
polymerization and an additional constriction step by dynamin have recently been 
implicated (Lee et al., 2016). 
 The biochemical properties of Drp1 are remarkably similar to that of dynamin. It 
is able to oligomerize, tubulate lipid templates, and bind and hydrolyze GTP in vitro 
(Smirnova et al., 2001; Mears et al., 2011; Koirala et al., 2013). Drp1 contains a GTPase 
domain, a BSE domain, a stalk domain, and in lieu of a PH domain, has so-called Insert 
B domain that has been shown to bind cardiolipin and is thought to mediate its interaction 
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with the mitochondrial outer membrane (Frohlich et al., 2013; Wenger et al., 2013; 
Bustillo-Zabalbeitia et al., 2014). In the cell, the majority of Drp1 appears cytosolic, with 
a fraction observed to assemble as punctate foci on the surface of mitochondria 
(Smirnova et al., 2001; Macdonald et al., 2014). Genetic ablation of Drp1 results in 
elongated mitochondria, whereas overexpression results in fragmented mitochondria 
(Labrousse et al., 1999; Ishihara et al., 2009; Wakabayashi et al., 2009). In mice, Drp1 is 
required for embryonic, brain, and heart development (Ishihara et al., 2009; Wakabayashi 
et al., 2009; Ashrafian et al., 2010). A lethal point mutation in the stalk domain of Drp1 
has been described in a human patient (Chang et al., 2010).  
Unlike the PH domain of dynamin, the Insert B domain of Drp1 is predicted to be 
largely unstructured, impeding efforts to crystallize the full-length protein (Frohlich et 
al., 2013). The structure of Drp1, minus this domain, closely resembles that of dynamin, 
with the exceptions of an additional loop in the GTPase domain with unknown function, 
and a putative fourth interaction interface hypothesized to create a tetramer perpendicular 
to the oligomerization interface. This tetrameric unit is proposed to produce a double-
beamed helical assembly instead of a single, spiraling row of polymers (Frohlich et al., 
2013). In addition to maintaining normal mitochondrial morphology, Drp1-mediated 
mitochondrial fission has also been demonstrated to be important for mitosis and 
apoptosis (Youle and Karbowski, 2005; Kashatus et al., 2011). Regulation of Drp1 
activity is primarily accomplished by phosphorylation at two different sites in the Insert 
B domain, though other post-translational modifications and modification sites exist 
(Chang and Blackstone, 2010).  
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Drp1 recruitment proteins 
 Drp1 primarily exists as a soluble dimer/tetramer equilibrium in the cytosol, and 
relies on outer mitochondrial membrane receptors to redirect it to the mitochondrial 
surface for membrane scission (Loson et al., 2013; Macdonald et al., 2014). In yeast, the 
only known receptors are mitochondrial fission protein 1 (Fis1), mitochondrial division 
protein 1 (Mdv1), and CCR4-associated factor 4 (Caf4) (Otera and Mihara, 2011). Fis1 is 
membrane-bound to the outer membrane, and forms a stable complex with one of the two 
cytosolic adaptors Mdv1 or Caf4 (Koirala et al., 2010; Zhang et al., 2012). A β-propeller 
domain in Mdv1 interacts with the Insert B domain of Dnm1 to recruit it to the 
mitochondrial surface (Bui et al., 2012). The mammalian homolog of Fis1 was initially 
expected to be the receptor for Drp1 but later shown to have little to no role in 
mitochondrial fission in cultured cell under basal conditions (Otera et al., 2010; Loson et 
al., 2013). Instead, the major receptors appear to be the membrane-bound mitochondrial 
fission factor (Mff), mitochondrial dynamics protein of 51 kDa (MiD51), and 
mitochondrial dynamics protein of 49 kDa (MiD49) proteins (Otera et al., 2010; Palmer 
et al., 2011; Zhao et al., 2011). 
 Mff is a C-tailed anchored protein discovered in 2008 as a mitochondrial and 
peroxisome-targeted protein required for recruiting Drp1 to mediate mitochondrial and 
peroxisomal fission, with homologs in mammals and flies but not yeast (Gandre-Babbe 
and van der Bliek, 2008). Like Drp1 depletion, Mff knockdown results in highly 
elongated mitochondria in mammalian cells (Gandre-Babbe and van der Bliek, 2008; 
Otera et al., 2010). In contrast to Drp1 knockout mice, mouse knockouts of Mff are not 
embryonically lethal, suggesting other receptors exist that compensate for the loss of Mff 
13 
 
during development in these mutants (Chen et al., 2015). These might be the MiD51 and 
MiD49 proteins, N-terminally anchored proteins discovered in 2011 as receptors for Drp1 
in screens aimed at finding proteins that affected mitochondrial morphology (Palmer et 
al., 2011; Zhao et al., 2011). Predominantly found in higher eukaryotes, knockdown of 
the MiDs results in loss of mitochondrial fission, but paradoxically, over-expression also 
results in inhibition of fission, despite observable Drp1 recruitment. These findings of 
have produced two models of MiD function, one in which it functions as an inhibitor of 
mitochondrial fission and one as a promoting factor. Crystal structures of the soluble 
domains of MiD51 and MiD49 show that they belong to a family of nucleotidyl 
transferase proteins, but as of yet no enzymatic function has described for either of these 
proteins (Loson et al., 2014; Richter et al., 2014; Loson et al., 2015). Simultaneous 
reduction of the MiD proteins and Mff, leads to additive increase in mitochondrial 
elongation, compared to of either alone, that almost recapitulates that seen in Drp1 
knockout cells (Otera et al., 2016; Loson et al., 2013). This suggests that these receptors 
have non-redundant roles in mediating Drp1 recruitment, and together account for the 
majority of Drp1 recruitment activity.  
 
Thesis outline 
 Drp1 recruitment to mitochondria is a necessary step for mitochondrial fission, 
and though the major receptors for Drp1 have been identified, many questions remain 
about the role of each receptor and overall mechanism of recruitment in mammalian cells. 
In yeast the model appears straightforward: Fis1, anchored to the outer mitochondrial 
membrane, complexes with soluble Mdv1 or Caf4, which in turn interacts with Dnm1 to 
14 
 
bring it to the mitochondrial surface. Mdv1 recruits Dnm1 through the insert B domain, 
and might also play a role as an effector protein in Dnm1 activation and assembly. The 
mammalian homolog of Fis1, however, appears to play a minor role in Drp1 recruitment 
under basal conditions, instead relinquishing this role to Mff and the MiD proteins. How 
Mff and MiD51 recruit Drp1 is unknown. In Chapter 2 of this thesis I examine the 
interaction between Drp1 and Mff to help understand the Drp1 recruitment process with 
respect to Mff. In Chapter 3, I examine how a point mutation of Drp1, recently 
discovered in patients presenting with encephalopathy and refractory epilepsy, affects its 
recruitment to mitochondria and mitochondrial morphology. In the concluding Chapter 4, 
I summarize my main findings, propose models of Mff and MiD function, and discuss 
future avenues of inquiry on the topic of Drp1 recruitment and regulation.  
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ABSTRACT 
Dynamin-related protein 1 (Drp1) is the GTP-hydrolyzing mechanoenzyme that 
catalyzes mitochondrial fission in the cell. Residing in the cytosol as dimers and 
tetramers, Drp1 is recruited by receptors on the mitochondrial outer membrane, where it 
further assembles into a helical ring that drives division via GTP-dependent constriction. 
The Drp1 receptor Mff is a major regulator of mitochondrial fission, and its 
overexpression results in increased fission. In contrast, the alternative Drp1 receptors 
MiD51 and MiD49 appear to recruit inactive forms of Drp1, because their overexpression 
inhibits fission. Using genetic and biochemical assays, we studied the interaction of Drp1 
with Mff. We show the insert B region of Drp1 inhibits Mff-Drp1 interactions, such that 
recombinant Drp1 mutants lacking insert B form a stable complex with Mff. Mff cannot 
bind to assembly-deficient mutants of Drp1, suggesting that Mff selectively interacts with 
higher order complexes of Drp1. In contrast, the alternative Drp1 receptors MiD51 and 
MiD49 can recruit Drp1 dimers. Therefore, Drp1 recruitment by Mff versus MiD51 and 
MiD49 may result in different outcomes because they recruit different subpopulations of 
Drp1 from the cytosol. 
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INTRODUCTION 
  
 Mitochondria are dynamic organelles that continuously undergo regulated 
cycles of fission and fusion. These processes are essential for maintaining mitochondrial 
health and function, and have important roles in mitochondrial DNA stability and 
inheritance, respiratory capacity, apoptosis, and mitophagy (Westermann, 2010; Chan, 
2012; Youle and van der Bliek, 2012). Fission is mediated by dynamin-related protein 1 
(Drp1), a member of the dynamin superfamily of GTPases (Smirnova et al., 2001). Like 
dynamin, Drp1 is a mechanoenzyme that has the capacity to self-assemble into 
oligomeric complexes that have enhanced GTP hydrolysis activity (Ferguson and De 
Camilli, 2012). In the cell, much of Drp1 resides in the cytosol but can be recruited to 
mitochondria via receptors anchored to the mitochondrial outer membrane (Loson et al., 
2013). Once recruited, Drp1 further assembles around the mitochondrial tubule to form 
an oligomeric ring that constricts and divides the mitochondrion in a GTP-dependent 
process (Ingerman et al., 2005; Mears et al., 2011). Mutation of Drp1 blocks 
mitochondrial fission, resulting in elongated mitochondrial networks due to unopposed 
mitochondrial fusion (Smirnova et al., 2001). This cellular defect causes developmental 
lethality in mice and multi-system disease in humans (Waterham et al., 2007; Ishihara et 
al., 2009; Wakabayashi et al., 2009). 
 
 Four receptors have been identified that recruit Drp1 to mitochondria: 
mitochondrial fission protein 1 (Fis1), mitochondrial fission factor (Mff), and 
mitochondrial dynamics proteins of 49 and 51 kDa (MiD49 and MiD51, respectively) 
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(Yoon et al., 2003; Gandre-Babbe and van der Bliek, 2008; Palmer et al., 2011; Zhao et 
al., 2011). Fis1, the first identified candidate receptor, has a minor role in Drp1 
recruitment (Otera et al., 2010; Loson et al., 2013), and recent results suggest instead a 
role in mitophagy (Shen et al., 2014; Yamano et al., 2014). There is good evidence that 
the latter three molecules are each capable of recruiting Drp1, as the loss of any of these 
receptors results in reduced Drp1 accumulation on mitochondria and increased 
mitochondrial tubule length (Palmer et al., 2011; Loson et al., 2013; Palmer et al., 2013). 
Mff appears to be the primary receptor. Loss of Mff results in the greatest reduction of 
fission in mouse embryonic fibroblasts, while overexpression causes mitochondrial 
fragmentation consistent with increased fission rates (Otera et al., 2010; Loson et al., 
2013). MiD51 and MiD49 both strongly recruit Drp1 and are associated with ER-
mitochondria contact sites (Zhao et al., 2011; Koirala et al., 2013; Palmer et al., 2013; 
Elgass et al., 2015). However, in contrast to Mff, overexpression of MiD51 or MiD49 
paradoxically results in mitochondrial elongation and inhibition of fission, presumably 
because they recruit an inactive form of Drp1 (Loson et al., 2013; Palmer et al., 2013).  
 
 An important issue is why Mff shows a different cellular behavior compared to 
MiD51 and MiD49. A route to addressing this issue is to examine the physical interaction 
between Drp1 and its receptors in vitro. However, such physical interactions have only 
been detected using cross-linking reagents, suggesting that the Drp1-receptor interactions 
are low affinity or transient (Otera et al., 2010; Strack and Cribbs, 2012). In yeast, the 
interaction between Dnm1 (the yeast ortholog of Drp1) and its receptor, Mdv1, is much 
more stable and has been linked to the insert B domain, which associates with the B-
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propeller domain of Mdv1 (Bui et al., 2012). In mammals, the analogous insert B domain 
is a largely unstructured domain that is targeted for control by post-translational 
modifications and interacts with cardiolipin to associate Drp1 with lipid membranes 
(Chang and Blackstone, 2010; Frohlich et al., 2013; Bustillo-Zabalbeitia et al., 2014; 
Stepanyants et al., 2015). Studies show that this domain is dispensable for Drp1 
hydrolysis, membrane constriction, and mitochondrial recruitment (Strack and Cribbs, 
2012; Francy et al., 2015). These results imply that in mammals, the Drp1-receptor 
interaction is not mediated through the insert B domain.  
 
 In this study we examine the interaction between Drp1 and Mff to gain 
mechanistic insight into Drp1 recruitment. Using a yeast two-hybrid assay, we identify 
minimal interacting regions on both Mff and Drp1, with a short N-terminal fragment of 
Mff being sufficient to bind the Drp1 stalk domain. We find that removal of the insert B 
domain from Drp1 greatly enhances the Drp1-Mff interaction, resulting in a stable 
complex in vitro in the absence of cross-linkers. Using a mutational screen, we identify 
mutants of Drp1 that specifically abolish recruitment via Mff but not MiD51. Analysis of 
these mutants indicates that Drp1 oligomerization is required for Mff, but not MiD51 or 
MiD49, to physically associate with Drp1. Together the results suggest that the robust 
fission activity of Mff stems from its ability to selectively recruit oligomerized Drp1 to 
the mitochondrial surface. 
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RESULTS 
 
The Mff N-terminal region and the Drp1 stalk form the core interaction unit 
To interrogate the Drp1-Mff interaction, we first sought to determine the minimal 
region of Mff necessary for binding Drp1. By comparing the polypeptide sequence of 
Mff from the human, mouse, fish, frogc and fly orthologs, several notable features can be 
noted (Figure 2.S1A). At the N-terminus, there are two repeat motifs (R1 and R2) that are 
required for recruiting Drp1 (Otera et al., 2010), as well as a third conserved motif (R3) 
that has no proposed function. Beyond R1-R3, there is a disordered region (Figure 
2.S1B), followed by a conserved coiled-coil (CC) domain required for dimerization and a 
C-terminal transmembrane domain (TM). Previous assays examining the Drp1-Mff 
interaction have been hampered by the apparent transience or instability of the complex, 
and therefore its detection required stabilization by cross-linking agents (Gandre-Babbe 
and van der Bliek, 2008; Otera et al., 2010; Strack and Cribbs, 2012). To detect this 
transient/unstable complex in the absence of cross-linkers, we developed a yeast two-
hybrid interaction assay that allowed us to examine Drp1 recruitment by Mff. Initial 
attempts with an Mff bait truncated just N-terminal to the transmembrane segment 
(Figure 2.1A) resulted in auto-activation (Figure 2.S2A). We reasoned that the acidic 
coiled-coil domain might be responsible and deleted it to generate three MffΔCC baits 
based on splice variants 1, 3, 4 (RefSeq NP_083685.2, NP_001297626.1, and 
NP_001297628.1, respectively) reported previously (Gandre-Babbe and van der Bliek, 
2008) (Figures 2.1A, 2.1B). Isoform 4 (Mff4ΔCC), the shortest construct, showed the 
most robust interaction, followed by isoform 3 (Mff3ΔCC) and then isoform 1 
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(Mff1ΔCC). To determine the minimal Mff region sufficient for recruiting Drp1, we 
made sequential C-terminal truncations of Mff and tested them against Drp1. Truncations 
that ended within the predicted disordered region retained binding, whereas truncations 
that deleted the R3 domain resulted in complete loss of recruitment (Figure 2.1C). Thus 
the N-terminal Mff region containing the three conserved R1-R3 motifs appeared 
sufficient for Drp1 binding. These results are consistent with experiments in cell culture 
indicating that R1 and R2 of Mff are essential for Drp1 recruitment (Otera et al., 2010). 
 
We similarly used the yeast two-hybrid assay to identify the Mff-interacting 
regions of Drp1. Structurally, Drp1 consists of 4 main domains: the GTPase domain, the 
bundle signaling element (BSE), the stalk region, and the insert B (IB) region (Figure 
2.1D) (Schmid and Frolov, 2011; Ferguson and De Camilli, 2012; Frohlich et al., 2013; 
Wenger et al., 2013). We tested the ability of Mff to recruit Drp1 constructs containing 
deletions of one or more of these domains (Figure 2.1E). Deleting the GTPase domain 
(ΔG) reduced the interaction between Mff1ΔCC and Drp1, and Mff3ΔCC and Drp1, but 
did not appreciably affect recruitment by Mff4ΔCC or smaller constructs. This suggests 
that the GTPase domain promotes but is not required for Drp1 interaction with Mff. Drp1 
constructs lacking the insert B domain (ΔIB), on the other hand, enhanced the interaction 
between Drp1 and Mff. The formerly weak recruitment by Mff isoforms 1 and 3 were 
now more robust, and new additional interactions between Drp1 and Mff fragments 1-
100, 1-61, and 1-50 (weakly) were now detected. These data suggest that the insert B 
domain is dispensable for the Drp1-Mff interaction and is in fact inhibitory. Removing 
the GTPase, BSE, and insert B domains (to generate the stalk alone) did not greatly alter 
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Drp1 interaction with Mff relative to Drp1ΔIB alone. The interaction data therefore 
suggest that the minimal regions required for the Drp1-Mff interaction are the Mff 
R1+R2 motifs and the Drp1 stalk domain.  
 
Removing insert B from Drp1 stabilizes the Drp1-Mff interaction in vitro 
The results from our two-hybrid analysis strongly suggest that the insert B region 
inhibits the interaction of Drp1 with Mff. Since previous efforts to demonstrate binding 
between Drp1 and Mff in vitro required cross-linking (Otera et al., 2010; Strack and 
Cribbs, 2012; Frohlich et al., 2013), we wondered whether removing the insert B region 
might stabilize the Drp1-Mff complex. To test this idea, we constructed a GST fusion 
protein containing the N-terminal 61 residues of Mff (the minimal binding fragment) and 
assayed its ability to bind full-length Drp1 or Drp1ΔIB in a GST pull-down assay (Figure 
2.2A). Whereas full-length Drp1 weakly co-immunoprecipitated, Drp1ΔIB showed 
efficient co-association with Mff, suggesting substantial stabilization of binding. The 
insert B domain of Drp1 therefore inhibits formation of a stable Drp1-Mff interaction. 
 
We further tested whether the Mff truncations examined in the yeast two-hybrid 
assay could similarly interact with Drp1 and Drp1ΔIB in the assay. Consistent with 
previous reports, we found poor binding between full-length Drp1 and the Mff constructs, 
even though such constructs show interaction in the two-hybrid assay (Figure 2.2B, top 
half). In contrast, Drp1ΔIB showed robust association with Mff (1-61) and Mff (1-50), 
and less binding to longer constructs (Figure 2.2B, bottom half). The larger number of 
interactions detected with the two-hybrid assay is consistent with the idea that the two-
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hybrid can detect weak or transient interactions (Van Criekinge and Beyaert, 1999) that 
are missed by biochemical assays. The pull-down results suggest that the strongest 
interacting pair is between Drp1ΔIB and Mff (1-61). To test the stability of this 
interaction, we mixed Mff (1-61)-GST with Drp1ΔIB and analyzed the mixture on an 
analytical size-exclusion column to test for a complex (Figure 2.2C). Compared to 
Drp1ΔIB or Mff (1-61)-GST alone samples (Figure 2.2C, left panel), the mixture showed 
a distinct peak migrating at a higher molecular weight, concomitant with a decrease in the 
peaks corresponding to individual Drp1ΔIB and Mff (1-61)-GST (Figure 2.2C, middle 
and third panels). To determine the identity of this size-shifted species, we collected and 
analyzed the fractions from the SEC runs and found that fractions corresponding to the 
new peak contained both Drp1ΔIB and Mff (1-61)-GST (Figure 2.2D), suggesting that 
Drp1ΔIB and Mff (1-61)-GST are co-migrating as a complex.  
 
Identification of Drp1 mutants that have selective loss of Mff versus MiD51 binding 
The identification of the stalk region of Drp1 as the Mff-interaction domain 
provided us with a smaller target for determining the interacting residues on Drp1. We 
previously utilized a mutation screening strategy to identify a Drp1-interacting loop on 
MiD51 (Loson et al., 2014). Similarly, we tested a series of Drp1 mutants for interactions 
with Mff in our yeast two-hybrid assay. The screening considerations were as follows: (1) 
We limited our mutations to surface-exposed residues of Drp1 with low homology to 
dynamin 2, as reasoned by the lack of an Mff interaction with dynamin 2 in our yeast 
two-hybrid assay (Figure 2.S2C); (2) Two Mff constructs of various binding efficiency 
(Figure 2.1A) were used as baits to provide additional sensitivity for the screen; (3) 
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Because previous studies indicated that the yeast two-hybrid assay provides a readout of 
Drp1 oligomerization (Naylor et al., 2006; Chang et al., 2010), we included a Drp1 bait 
to obtain information about the oligomerization activity of the Drp1 mutants; (4) Because 
Mff-specific mutants were desired, MiD51 was included as a bait to screen against Drp1 
mutants that also affected MiD51 binding. 
 
We assayed 42 Drp1 mutants (Figure 2.3A, Table S1) for binding to the Mff, 
Drp1, and MiD51 baits. Several interesting patterns emerged from the screen. All 
mutants that affected Drp1 oligomerization, as interpreted by loss of interaction with the 
Drp1 bait, also abolished binding to Mff (Figure 2.3A: Mutants 8, 9, 15, 18, 20). In 
contrast, some of these mutants retained MiD51 binding (Mutants 9, 15). Loss of Drp1 
oligomerization therefore correlates tightly with loss of Mff binding but not MiD51 
binding. In addition, we recovered several Drp1 mutants that failed to bind Mff, but 
retained binding to both Drp1 and MiD51. We chose six for further study (Mutants 10, 
13, 16, 17, 22, 28) and introduced them into a Drp1ΔIB background to test whether 
removing the insert B domain could rescue the loss of binding (Figure 2.3B). In three of 
six mutants we found recovery of interaction with Mff, consistent with the notion that the 
insert B domain is inhibitory to the interaction. This secondary screen left us with three 
mutants that we interpret as bona fide Mff-binding mutants for further characterization 
(Figure 2.3C). We tested the three mutants in our in vitro interaction assays to validate 
the results of the yeast two-hybrid assay. Whereas wild-type Drp1ΔIB binds robustly to 
Mff (1-61), all three mutants (in the context of Drp1ΔIB) failed to co-precipitate with Mff 
(1-61) by GST pull-down (Figure 2.4A). Furthermore, by SEC analysis, these mutants 
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showed loss of complex formation with Mff (1-61) (Figure 2.4B). Together the data 
suggests that these mutants are indeed defective in Mff binding. 
 
Drp1 mutants are defective for fission, mitochondrial recruitment and are specific 
to Mff versus MiD51 and MiD49 
To assess the physiological function of these mutants, we expressed them in 
Drp1-null mouse embryonic fibroblasts (MEFs). Due to loss of mitochondrial fission, 
Drp1-null MEFs have highly elongated and interconnected mitochondria. Re-expression 
of wild-type Drp1 restores mitochondrial fission, resulting in shorter mitochondrial 
tubules (Figure 2.5A). In contrast, expression of the three Drp1 mutants defective in Mff 
binding did not shorten the mitochondrial network, indicating that they are nonfunctional 
for fission (Figure 2.5A). To understand this defect, we assessed whether localization of 
the Drp1 mutants to mitochondria was impaired. Because the strong cytosolic signal of 
over-expressed Drp1 obscured this analysis, we briefly permeabilized the cells with 
digitonin to remove soluble Drp1 before immunostaining. This treatment artifactually 
resulted in mitochondrial fragmentation but greatly improved the visualization of Drp1 
complexes on the mitochondria (Figure 2.5B). In wild-type cells, there is a substantial 
amount of endogenous Drp1 localized to mitochondria. In Mff-null cells, there is little 
Drp1 on mitochondria, consistent with its role as the major Drp1 recruiter (Otera et al., 
2010; Loson et al., 2013). When wild-type Drp1 is expressed in Drp1-null cells, there is 
robust recruitment of Drp1 on the mitochondria (Figure 2.5B, magnification insets). In 
contrast, the three Mff-binding mutants show a major loss of Drp1 puncta on 
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mitochondria (Figure 2.5B, magnification insets). Mutant 17 appears to form aggregates 
in the cell, but the majority of these aggregates did not co-localize with mitochondria. 
 
To determine whether these mutants are selectively defective for Mff binding, we 
tested their recruitment by ectopically targeted Mff, MiD51 and MiD49. FLAG-tagged 
versions of the three Drp1 receptors were targeted to lysosomes by fusion to lysosomal-
associated membrane protein 1 (LAMP1). These constructs were expressed in Drp1-null 
cells, and localization of wild-type Drp1 versus mutant Drp1 was assessed (Figure 2.6). 
When wild-type Drp1 was expressed, it was robustly recruited to FLAG-positive puncta 
in the Mff-, MiD51-, and MiD49-expressing cell lines (Figure 2.6A). When the three 
Drp1 mutants were expressed, they strongly localized to FLAG-positive puncta in the 
lysosome-targeted MiD51 and MiD49 cell lines, but not in the lysosome-targeted Mff 
cell line (Figures 2.6B, C and D). Together the data suggest that mutants 10, 16, and 17 
specifically disrupt the interaction of Drp1 with Mff, but not MiD49 or MiD51, and that 
the major reduction of Drp1 puncta on mitochondria observed (Figure 2.5B) can be 
attributed specifically to loss of Mff-mediated recruitment. 
 
Oligomerization-dependent recruitment of Drp1 by Mff 
In our two-hybrid screen for Drp1 mutants defective for Mff binding, we 
explicitly screened against mutants that had defects in oligomerization and ultimately 
recovered three mutants that fulfilled our criteria. However, the results from the screen 
suggested that Drp1 oligomerization is tightly associated with its ability to bind Mff, as 
every Drp1 mutant defective in oligomerization is also deficient in Mff binding. We 
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therefore wondered if the identified mutants (10, 16, 17) might have a moderate 
oligomerization defect that was not detectable in the yeast two-hybrid assay. This 
concern was increased by the observation that the mutated residues are located adjacent 
to known oligomerization loops for Drp1 and dynamin (Figure 2.3C) (Frohlich et al., 
2013; Reubold et al., 2015). For these reasons, we considered the possibility that the 
yeast two-hybrid screen may not have provided a sufficiently stringent filter against 
oligomerization mutants. We therefore performed two independent tests of 
oligomerization activity to assess the behavior of the mutants against that of wild-type 
and a known mutant termed 4A (the four residues 401GPRP404 mutated to AAAA) that 
forms dimers but cannot form tetramers or higher order oligomers (Frohlich et al., 2013). 
In a GTPγS-stimulated assembly assay, about 50% of Drp1 sediments when incubated in 
50 mM NaCl (Figure 2.7A). In contrast, the 4A mutant is almost completely deficient in 
assembly and remains highly soluble. Mutants 16 and 17 sedimented substantially less 
than wild-type Drp1, but more than the dimeric 4A mutant. Mutant 10 did not show a 
clear sedimentation defect. Under low salt conditions that promote oligomerization, SEC 
analysis of the mutants show that mutants 10, 16, and 17 all migrate substantially more 
slowly than wild-type, indicating a defect in forming higher order oligomers (Figure 
2.7B). Mutant 17 migrated similarly to the 4A mutant, whereas mutants 10 and 16 
showed a somewhat less pronounced defect. Together the results suggest that all three 
mutants can form dimers but are inefficient at further oligomerization, although the 
defects are not as strong as the canonical 4A oligomerization mutant. 
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If Drp1 oligomerization is necessary for Mff binding, then our model predicts that 
the 4A mutant would be unable to bind Mff. To test this we examined the mutant in the 
yeast two-hybrid assay (Figure 2.7C), the GST pull-down assay (Figure 2.7D), and the 
complex formation assay (Figure 2.7E). Consistent with our model, we find that the 4A 
mutant shows strong defects in Mff association in all assays. Importantly, the two-hybrid 
assay shows that 4A has normal binding to MiD51. 
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DISCUSSION 
Mff is likely to be the major Drp1 receptor. Cells lacking Mff, compared to the 
other receptors (Fis1, MiD51, MiD49), show the most highly elongated mitochondria 
(Otera et al., 2010; Loson et al., 2013). However, the lack of a stable interaction between 
the two proteins in vitro has been puzzling. Here we show that recombinant Drp1 lacking 
the insert B region, unlike full-length Drp1, forms a stable complex with the N-terminal 
region of Mff.  This observation indicates that insert B inhibits Drp1 binding to Mff. In 
contrast to the mammalian situation, insert B in yeast Dnm1 has been shown to promote 
binding to the Mdv1/Fis1 receptor complex (Bui et al., 2012). It is tempting to speculate 
that the mammalian Drp1 insert B domain may regulate mitochondrial fission by 
dampening Drp1-Mff interactions until signals to activate fission are present. To 
understand this issue, it will be important to determine how the inhibitory effect of insert 
B on Mff binding is modulated. Because insert B has been shown to interact with 
cardiolipin (Bustillo-Zabalbeitia et al., 2014; Macdonald et al., 2014; Ugarte-Uribe et al., 
2014; Stepanyants et al., 2015), the possible role of lipids in regulating Drp1-Mff 
interactions should be tested. In addition, it is interesting to note that insert B contains 
residues are targeted for phosphorylation and sumoylation (Figueroa-Romero et al., 2009; 
Chang and Blackstone, 2010). Phosphorylation of serine-616 in human Drp1 
(corresponding to serine-579 in mouse Drp1) activates its fission activity (Taguchi et al., 
2007; Kashatus et al., 2011). This serine residue resides in insert B, but phosphomimetic 
mutants of this residue do not increase the binding of full-length Drp1 to Mff in vitro 
(Figure 2.S3). 
 
39 
 
Our analysis of Drp1 mutants that are deficient for Mff binding suggests that the 
oligomerization state of Drp1 is closely linked to its interaction with Mff. In the cytosol, 
Drp1 exists in a dimer/tetramer/high-order equilibrium, with data supporting either 
tetramers and dimers as the predominant species (Zhu et al., 2004; Koirala et al., 2013; 
Macdonald et al., 2014). Our mutational screen shows that Mff is unable to stably 
associate with Drp1 that is oligomerization-defective. Importantly, our mutations do not 
disrupt the Drp1 monomer:monomer interaction surface (termed "interface 2") in the 
stalk region that is important for formation of the cross-like stalk dimer (Ferguson and De 
Camilli, 2012; Frohlich et al., 2013). Like the 4A mutant, mutants 10, 16, and 17 are all 
capable of forming dimers, but are defective in formation of higher order states. 
Therefore, it appears that the Drp1 oligomeric state recruited by Mff is a tetramer or 
higher. In contrast, MiD51 and MiD49 do not show this strong requirement for Drp1 
oligomerization. 
 
Two general models can explain why Mff strongly prefers a higher order state of 
Drp1. For simplicity in presenting the models, we will assume that Mff binds to a Drp1 
tetramer, although the bound form may be a larger assembly. In the first model, the Mff-
binding site is generated only when two Drp1 dimers form a tetramer.  The cross-like 
Drp1 dimers come together through apposition of their stalk domains, forming a new 
surface that is now directly recognized by the N-terminal region of Mff. In the second 
model, the Mff binding surface exists in the Drp1 dimer, but formation of the Drp1 
dimer:dimer complex is required for stability. In both cases, the functional result is that 
only the oligomerized form of Drp1 is recruited, while Drp1 dimers are left in the 
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cytosol. Both models are consistent with the observation that the Mff-binding unit 
consists of the Drp1 stalk, which contains the interfaces supporting Drp1 tetramerization 
(Frohlich et al., 2013; Francy et al., 2015; Reubold et al., 2015). Because Mff has a 
coiled coil domain, it is also possible that Mff dimerization may facilitate formation of 
additional Drp1-Drp1 interactions. In yeast, Mdv1 functions to nucleate Dnm1 assembly 
(Lackner et al., 2009). 
 
In binding only to higher order Drp1 oligomers, Mff differs strikingly from 
MiD51 and MiD49. Our studies show that the latter proteins are still able to bind Drp1 
mutants that can only form dimers. In this regard, the Drp1-MiD interaction resembles 
that of yeast Dnm1-Mdv1, which is not affected by oligomerization-defective mutations 
in Dnm1 (Ingerman et al., 2005; Bhar et al., 2006). These results underscore a major 
difference between Mff- and MiD-mediated recruitment, and may explain their distinct 
cellular effects. In cells, over-expressed Mff results in increased fission (Otera et al., 
2010). In contrast, over-expressed MiD51 or MiD49 results in high accumulation of Drp1 
on mitochondria, but the net effect is reduced fission and mitochondrial elongation 
because the recruited Drp1 is inactive (Loson et al., 2013; Palmer et al., 2013). We 
speculate that by selectively recruiting the subpopulation of Drp1 that is oligomeric, Mff 
might be recruiting an active pool of Drp1 that is fission-competent. In contrast, the MiDs 
appear to recruit an inactive Drp1 population, including dimers, that requires an 
additional trigger before fission induction (Figure 2.7F). 
 
 
  
41 
 
MATERIALS AND METHODS 
 
Cloning for protein expression 
Mouse Drp1 isoform b (699 amino acids), Drp1ΔIB (1-513 fused to 603-699), Drp1ΔIB 
4A (401GPRP404 mutated to AAAA), Drp1 mutants 10, 16 and 17 (mutations described 
in Table S1) were cloned into the NdeI and BamHI sites of a modified pET21b+ vector 
containing a downstream PreScission Protease cleavage site (Novagen). Mouse Mff 
isoform 4ΔCC, Mff (1-50), Mff (1-61), Mff (1-102), and Mff (1-146) were cloned into 
the NdeI and BamHI sites of a modified pET28a(+) vector containing a downstream 
PreScission Protease cleavage site and GST tag (Novagen). The parental vector, which 
produces a tagged GST, was used to express the T7-GST negative control used in GST 
pull-down assays. OPA1 (262-1015, Isoform 8), used as a negative control in GST pull-
down assays, was cloned into a modified pET28a(+) vector with an upstream PreScission 
Protease site. Mutants were generated by overlap PCR mutagenesis and verified by 
sequencing.  
 
Protein expression and purification 
Recombinant protein was expressed in Rosetta (DE3) BL21 E. coli (Novagen). 
Transformed bacteria were grown in 1 liter of terrific broth containing 25 µg/mL 
chloramphenicol and either 100 µg/mL ampicillin (pET21 vectors) or 50 µg/mL 
kanamycin (pET28 vectors) at 37°C to an OD600 of 1.5, shifted to 16°C and induced with 
0.5 mM isopropyl β-D-1-thiogalactopyranoside for overnight expression, typically 18 
hours. Cells were harvested and pellets were stored at -20°C. For His6-tagged proteins, 
cell pellets were thawed and resuspended in buffer containing 25 mM 4-(2-
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hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) pH 7.8, 500 mM NaCl, 10% 
glycerol, 5 mM β-mercaptoethanol (β-Me) (His Lysis Buffer) plus 5 mM Imidazole and 
1X HALT protease inhibitors (Thermo-Pierce, Rockford, IL), lysed by sonication, and 
cleared by centrifugation at 43,000 x g, for 30 minutes at 4°C. Supernatant was applied to 
1 mL bed volume of washed Talon beads (Clontech) for 3 hours, washed with His Lysis 
buffer plus 20 mM Imidazole, and exchanged into buffer containing 20 mM HEPES, pH 
7.5, 300 mM NaCl, 10% glycerol, and 2 mM β-Me for overnight cleavage (typically 20 
hours) with 60 units of PreScission Protease (GE Healthcare). Following cleavage, 
glutathione sepharose 4B beads (GE Healthcare) were added to remove the PreScission 
Protease and elutions were loaded onto a HiLoad Superdex 200 16/60 column (GE 
Healthcare) driven by an AKTA Purifier (Amersham) and pre-equilibrated with buffer 
containing 20 mM HEPES pH 7.5, 300 mM NaCl, 5% glycerol, and 5 mM β-Me for size-
exclusion chromatography purification. Peak fractions were collected and concentrated in 
Amicon-Ultra 15 concentrators, 50 MWCO (Millipore). Proteins were flash frozen and 
stored at -80°C. For Mff-GST proteins, the lysis, coupling to glutathione sepharose 
beads, and washes were performed in buffer containing 20 mM HEPES, pH 7.5, 300 mM 
NaCl, 10% glycerol, and 5 mM β-Me. GST fusion proteins were eluted with 10 mM 
reduced glutathione (Sigma) in buffer containing 20 mM HEPES, pH 7.5, 150 mM NaCl, 
10% glycerol, and 5 mM β-Me, desalted with Zeba desalting columns, 7 MWCO (Life 
Technologies) pre-equilibrated with buffer without glutathione, flash frozen, and stored at 
-80°C. For the Drp1-Mff co-migration SEC assays, Mff (1-61)-GST was additionally 
purified by size exclusion chromatography as above, with peak fractions collected and 
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concentrated in Amicon Ultra 15 concentrators, 30 MWCO, before freezing and storage 
at -80°C.  
 
Yeast Two-Hybrid Assay 
The Drp1 constructs in Figure 2.1E consist of the following truncations and fusions: FL, 
full-length Drp1, amino acids (aa) 1-699; ΔG, Drp1 minus the GTPase domain, aa309-
667; ΔIB, Drp1 minus the insert B domain, aa1-508 fused to aa605-699 with a 
GGGSGGS linker; Stalk, Drp1 minus the GTPase, BSE and insert B domains, aa329-508 
fused to aa605-662 with a GGGSGGS linker; Insert B domain, aa493-605; G+BSE 
domain, aa1-328 fused to 674-699 with a KHGTDSRV linker (Chappie et al., 2010). 
Mouse Dynamin 2, Drp1 isoform b, Drp1ΔIB 4A, Drp1 truncations and mutants in 
Figure 2.1E and Table 2.S1, MiD51 (47-463), MffΔTM (Δ272-291), MffΔCC (Δ235-
291), and Mff truncations in Figure 2.1C, were cloned (into either the pGAD-C1 or 
pGBDU-C1 vectors) and transformed into PJ69-4α and PJ69-4a yeast strains, 
respectively. Transformants were selected with leucine- and uracil-deficient plates, 
respectively, and haploid combinations for interaction testing were mated by spotting on 
YPD plus adenine plates. Diploids were selected by replica-plating onto leucine- and 
uracil-deficient plates (labeled as +Adenine in the figures) and interactions were assayed 
following replica-plating on leucine-, uracil- and adenine-deficient plates (labeled as -
Adenine in the figures). Growth on adenine-deficient plates indicates a positive 
interaction, and interaction tests were performed at least three times. Mutants were 
generated by overlap PCR mutagenesis and verified by sequencing. Residues for the 
mutational screen were selected from the set of accessible surface area residues as 
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determined by the “Surface Residues” function in Pymol, using a solvent radius of 2.5 
angstroms applied to the structure of Drp1 (PDB file 4BEJ). 
 
GST pull-downs assays 
Each GST-fusion and target protein pair was incubated with washed glutathione 
sepharose beads in buffer containing 20 mM HEPES, pH 7.5, 150 mM NaCl, 10% 
glycerol, 0.1% Triton X-100, 2 mM MgCl2, and 5 mM β-mercaptoethanol, at room 
temperature for 1 hour. The beads were washed twice with buffer and the bound fraction 
was analyzed by SDS-PAGE followed by Coomassie staining. For target proteins, 10% 
of the input amount is shown. 
 
Cell lines and cell culture 
All cell lines were cultured in DMEM containing 10% fetal bovine serum, 100 I.U./ml 
streptomycin and 100 µg/ml penicillin. Mff-null cell lines were previously published 
(Loson et al., 2013). Drp1-null cell lines were a generous gift from Katsuyoshi Mihara 
(Kyushu University, Fukuoka, Japan). Drp1-null cells lines stably expressing Drp1 and 
Drp1 mutants were generated by retroviral transduction of pQCXIP (Clontech) vectors 
with Kozak-Drp1 cloned into the BamHI/EcoRI sites, and maintained in 0.5 µg/mL 
puromycin.  
 
To generate the LAMP1 constructs, the Kozak sequence and FLAG-tag-Strep-tagII was 
fused to the rat Lamp1 sequence to generate a Kozak-LAMP1-FLAG construct, which 
was then fused to the N-terminus of Mff, MiD51, and MiD49. LAMP1-FLAG-Mff 
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Isoform 4 ΔTM (Δ272-291), LAMP1-FLAG-MiD51(134-463), and LAMP1-FLAG-
MiD49 (124-454) were cloned into the XhoI/HpaI sites of pMSCVhyg (Clontech), 
retrovirally transduced into Drp1-null cell lines expressing Drp1 or Drp1 mutants, and 
maintained with 0.5 µg/mL puromycin and 100 µg/mL hygromycin. 
 
Immunofluorescence and imaging 
For immunostaining, antibodies to Drp1 (mouse anti-Dlp1, BD Biosciences, San Diego, 
CA), Tom20 (rabbit anti-Tom20, Santa Cruz Biotechnology, Santa Cruz, CA) and FLAG 
(rabbit anti-FLAG, Sigma-Aldrich, St. Louis, MO) were used. Cells were grown in 
LabTek chambered glass slides (Nunc, Rochester, NY) for fixed-cell imaging. Cells were 
fixed in pre-warmed 4% formaldehyde for 10 minutes at 37°C, permeabilized in 0.1% 
Triton X-100, and incubated with antibodies in 5% fetal calf serum. For cytosol clearing 
of soluble Drp1, cells were permeabilized with 0.005% digitonin in buffer containing 20 
mM HEPES, pH 7.3, 110 mM potassium acetate, 2 mM magnesium acetate, 0.5 mM 
ethylene glycol tetraacetic acid (EGTA), 220 mM mannitol, 70 mM sucrose, and 2 mM 
fresh dithiothreitol for 90 seconds at room temperature, then fixed and immunostained as 
above. Scoring of mitochondrial morphology was performed blind to genotype in 
triplicates of 100 cells. Imaging was performed with a Plan-Apochromat 63x/1.4 oil 
objective on a Zeiss LSM 710 confocal microscope driven by Zen 2009 software (Carl 
Zeiss, Jena, Germany). Images were cropped, globally adjusted for contrast and 
brightness, and median filtered using ImageJ (National Institutes of Health, Bethesda, 
MD).  
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Size exclusion chromatography 
For the analysis of Drp1-Mff complex formation, 80 µg Drp1ΔIB/mutants and 80 µg Mff 
(1-61)-GST were incubated separately or together in 100 µL of 20 mM HEPES, pH 7.5, 
150 mM NaCl, 10% glycerol, 2 mM MgCl2, and 5 mM β-Me for 1 hour at room 
temperature, filtered through a  0.1µm Durapore filter column (EMD Millipore), and 
loaded onto a Shodex KW804 column (Wyatt Technology, Goleta, CA) driven by a 
Varian HPLC (Varian Inc, Palo Alto, CA) at 0.5 mL/min. Fractions were collected 
manually at 1 minute intervals. For analysis of oligomerization, 12.5 µM Drp1 was 
incubated in the above buffer at 100 mM NaCl prior to loading onto the column. 
 
Pelleting assay 
15 µM Drp1 or mutants were incubated in buffer containing 20 mM HEPES, pH 7.5, 50 
mM NaCl, 2 mM MgCl2, 5mM β-Me, and 1mM GTPγS for 30 minutes at room 
temperature, then centrifuged at 100,000 x g with a TLA100.3 rotor in a Beckman 
Optima MAX Ultracentrifuge for 20 minutes at 22°C. Supernatants were removed, and 
the pellet was resuspended in an equal volume of buffer. Equal amounts of supernatant 
and pellets were analyzed by SDS-PAGE followed by Coomassie staining. 
 
Sequence alignments and analysis 
Sequence alignments were performed with MultAlin (Corpet, 1988) and formatted with 
ESPript (Robert and Gouet, 2014). Disorder prediction was performed with DisMeta 
(Huang et al., 2014). 
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FIGURE LEGENDS 
 
Figure 2.1. The N-terminal region of Mff binds the Drp1 stalk domain. 
(A) Diagram of three Mff isoforms (top three lines) and key Mff constructs (bottom four 
lines) used in this study. (B) Interaction of Mff isoforms 1, 3 and 4 with Drp1 in the two-
hybrid assay. Mouse Mff isoforms 1, 3, and 4 with the coiled-coil domain deleted (ΔCC) 
were expressed from the pGBDU vector as GAL4 DNA-binding domain (BD) fusion 
proteins and tested against Drp1 expressed from the pGAD vector as GAL4 activation 
domain (AD) fusion proteins. For all two-hybrid assays in this study, growth on adenine-
deficient plates indicates an interaction. The AD only and BD only samples are negative 
controls. (C) Deletion analysis of Mff. Mff fragments beginning from amino acid 1 to the 
number indicated above each column were expressed as BD-fusion proteins and tested 
against Drp1 expressed as AD fusion proteins. Mff (1-110) is uninformative due to auto-
activation (Adenine-deficient plate shows growth with AD only). (D) Ribbon diagram of 
Drp1 structure, from PDB file 4BEJ. The major domains of Drp1 are highlighted. (E) 
Domain analysis of Drp1. Mff truncations were expressed as BD fusion proteins and 
tested against Drp1 truncations expressed as AD fusion proteins. FL: full-length Drp1, 
ΔG: Drp1 minus the GTPase domain, ΔIB: Drp1 minus the insert B domain, Stalk: Drp1 
minus the GTPase, bundle signaling element (BSE) and insert B domains, G+BSE 
domain: GTPase plus the BSE domain. The associated diploid selection plates are shown 
in Supplementary Figure 2.S2. 
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Figure 2.2. Mff61 and Drp1ΔIB form a stable complex. 
(A) GST pull-down assays for purified recombinant Drp1 (full-length), Drp1ΔIB, or 
OPA1 versus purified recombinant Mff61-GST (Mff fragment 1-61 fused C-terminally to 
GST) or T7-GST (T7tag-fused to GST). Shown are Coomassie-stained bands of either 
the input protein (lanes 1-3) or eluates from the pull-downs (lanes 4-9) following 
separation by SDS-PAGE. In lanes 4-9, the bottom row shows the isolated GST fusion 
proteins. The top row depicts the co-immunoprecipitated proteins. (B) GST pull-down 
assays for purified recombinant full-length Drp1 (upper half) or Drp1ΔIB (bottom half) 
versus purified recombinant Mff truncations. Shown are Coomassie-stained bands of the 
input Drp1ΔIB or full-length Drp1 proteins (lane 1) and eluates from the pull-downs 
(lanes 2-7) following separation by SDS-PAGE. The Drp1ΔIB or Drp1 FL row depicts 
the respective proteins pulled down by the GST fusion proteins in the lower row. (C) 
Size-exclusion chromatography (SEC) analyses of Drp1ΔIB and Mff61-GST. Left panel: 
UV absorbance profiles of elutions from a SEC run of either purified recombinant Mff61-
GST alone (in red) or purified recombinant Drp1ΔIB alone (in blue). Middle panel: UV 
absorbance profile of elutions from a SEC run of Mff61-GST and Drp1ΔIB pre-incubated 
together for an hour before loading, overlaid on top of the profiles from the left panel. 
Arrowheads depict a loss of Mff61-GST and Drp1ΔIB UV signal in the mixed sample. 
The arrow depicts the formation of a new peak eluting at an earlier time, indicating the 
formation of higher molecular weight species. Right panel: Magnification of the middle 
panel to highlight the size-shifted species of the new peak (underneath the bracket) from 
the Mff61-GST+Drp1ΔIB run. (D) SDS-PAGE analysis of fractions collected from the 
SEC runs in (C). Fractions from the times indicated at the top were collected from the 
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SEC runs in (C), resolved by SDS-PAGE and Coomassie-stained. The top panel depicts 
the Drp1ΔIB bands from the Drp1ΔIB only run, the middle panel depicts the Drp1ΔIB 
and Mff61-GST bands (arrows) from the combined run, and the bottom panel depicts the 
Mff61-GST bands from the Mff61-GST only run. The brackets highlight the presence of 
both Drp1ΔIB and Mff61-GST in the combined run not present in the individual runs, 
indicating a Drp1-Mff complex.  
 
Figure 2.3. Identification of Drp1 mutants that fail to bind Mff. 
(A) Screen of Drp1 mutants by the yeast two-hybrid assay. Full-length Drp1 and Drp1 
mutants 1 to 42 (see Table S1) were expressed as AD fusion proteins and tested against 
Mff104 (Mff fragment 1-104), Mff isoform 4 with its coiled-coil domain deleted 
(Mff4ΔCC), full-length Drp1, and MiD51 expressed as BD fusions. The adenine-
deficient plates are shown. The associated diploid selection plates are shown in 
Supplementary Figure 2.S2. Brackets indicate Drp1 mutants that did not interact with 
Mff, black asterisks denote Drp1 mutants that did not interact with Drp1 (indicating loss 
of oligomerization ability), and red asterisks denote the subset of Mff-binding deficient 
mutants that were selected for further characterization. (B) Secondary screen for Drp1 
mutants. The indicated Drp1 mutants were screened against full-length Drp1, Mff104, 
Mff4ΔCC, and Mff146 (Mff fragment 1-146). The Drp1 mutants were constructed in 
full-length Drp1 (FL) and Drp1ΔIB. The adenine-deficient plates are shown. The 
associated diploid selection plate are shown in Supplementary Figure 2.S2. Mutants 
highlighted in red from the Drp1ΔIB assay were selected for further characterization. (C) 
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Location of mutations 10, 16, and 17 indicated on the structure of Drp1 (PDB file 4BEJ). 
Loops implicated in higher order assembly of Drp1 are marked. 
 
Figure 2.4. Drp1 mutants display loss of interaction with Mff in vitro. 
(A) GST pull-down assays for purified recombinant Drp1 variants against purified 
recombinant Mff61-GST or T7-GST. Shown are Coomassie-stained bands of either the 
input protein (10% input lanes) or eluates from the pull-downs (GST pull-down lanes) 
following separation by SDS-PAGE. The top row (lanes 5-12) depicts the Drp1 proteins 
pulled down by the GST fusion proteins in the bottom row. (B) Size-exclusion 
chromatography analyses of Mff61-GST with Drp1ΔIB and Drp1ΔIB mutants. For 
Drp1ΔIB and each mutant, two SEC runs were performed, one with Mff61-GST and one 
without. Depicted are overlays of the UV absorbance profiles from the two separate runs. 
The brackets highlight the elution time during which the Drp1-Mff complex appears in 
the Drp1ΔIB (wild-type) + Mff61-GST run. This complex is absent in runs with the Drp1 
mutants. In the upper left panel, the arrowhead highlights the reduction in Drp1 signal 
from the combined run, relative to the original peak position in the Drp1ΔIB alone runs 
(dotted). The corresponding signals in the mutant samples do not show a decrease. 
 
Figure 2.5. Drp1 mutants lack fission activity and are not recruited to mitochondria. 
(A) Fission activity upon expression in Drp1-null MEFs. Wild-type MEFs, Drp1-null 
MEFs, and Drp1-null MEFs expressing wild-type Drp1, Drp1 Mutant 10, Drp1 Mutant 
16, or Mutant 17 were immunostained against Tom20 to visualize their mitochondrial 
morphology and scored into 3 categories: fragmented, short tubular, or elongated with 
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swelled mitochondria. Quantitation was done in triplicate, with 100 cells scored per 
experiment. Error bars, SEM. (B) Analysis of Drp1 recruitment to mitochondria. The cell 
lines indicated were briefly permeabilized with digitonin to clear cytosolic Drp1 before 
fixation. Mitochondria were fragmented in the process, but Drp1 puncta remained on 
mitochondria for visualization by immunostaining with an antibody against Drp1 (Drp1, 
green). Mitochondria were visualized by immunostaining against the outer membrane 
protein Tom20 (Mito, red). Cells were imaged and images were processed under identical 
settings to properly assess changes in Drp1 levels from cell to cell. The Drp1 signal, 
mitochondrial signal, and merged signals are shown. Squares to the right are 
magnifications of the boxed region in the main image. 
 
Figure 2.6. Drp1 mutants are recruited by MiD51 and MiD49, but not Mff. 
(A-D) FLAG-tagged Mff isoform 4, MiD51Δ, and MiD49 were targeted to lysosomes by 
fusion with the lysosomal-associated membrane protein 1 (LAMP1) protein in Drp1-null 
cells expressing wild-type (A) or mutant Drp1 (B-D). These cells were fixed and 
immunostained against Drp1 (green) and FLAG (red) for assessment of co-localization. 
The boxes regions are magnified. 
 
Figure 2.7. Drp1 oligomerization is required for binding to Mff. 
(A) Sedimentation analysis of Drp1 assembly. Purified recombinant full-length Drp1, 
mutants 10, 16, 17 and the oligomerization mutant 4A were incubated with GTPγS in 50 
mM salt for 30 minutes.  Assembled Drp1 was pelleted by sedimentation at 100,000x g. 
Equivalent volumes of the supernatant (S) and pellet (P) were loaded and resolved by 
53 
 
SDS-PAGE. Numbers below show the percentages in the supernatant and pellet, based on 
densitometry measurements. (B) Size-exclusion chromatography analysis of full-length 
Drp1 and mutants. Purified recombinant full-length Drp1, mutants 10, 16, 17, and the 
oligomerization mutant 4A were analyzed by size-exclusion chromatography under 
medium salt conditions (100 mM NaCl) to assess their ability to form higher order 
oligomers. 4A (red) is known to run as a dimer. Protein eluting before this peak is 
considered to represent higher order oligomers. (C) Analysis of the 4A mutant by the 
yeast two-hybrid assay. Drp1, Mff104, and MiD51 were expressed as BD fusion proteins 
and tested against Drp1, Mutants 10, 16, and 17, and the oligomerization mutant 4A 
expressed as AD fusion proteins. (D) Analysis of the 4A mutant by GST pull-down. 
Shown are Coomassie-stained bands of either the input protein (10% input lanes) or 
eluates from the pull-downs (GST pull-down, lanes 4-9) following separation by SDS-
PAGE. The top row depicts the Drp1 protein pulled down by the GST fusion proteins in 
the bottom row. (E) Analysis of the 4A mutant by size-exclusion chromatography (SEC). 
Depicted are overlays from SEC runs of the 4A mutant with and without Mff61-GST. 
The brackets highlight the absence of a Drp1-Mff complex at the expected elution time 
(compare to Figure 2.4B). (F) Model of differential recruitment of Drp1 by Mff versus 
MiD51 and MiD49. Drp1 exists in the cytosol as a pool of dimers (cross) and tetramers 
(two adjacent crosses). Whereas MiD51 and MiD49 (MiDs, left) can recruit Drp1 dimers, 
Mff (right) requires oligomerization of Drp1 dimers. The Drp1 recruited by MiD51 and 
MiD49 remains inactive unless additional cellular signals are triggered. For simplicity, 
Mff is depicted as recruiting tetramers, but it is possible that the recruited form of Drp1 is 
in a higher assembly state.  
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SUPPLEMENTAL FIGURE LEGENDS 
 
Figure 2.S1. Mff sequence analysis. 
(A) Multiple sequence alignment of Mff orthologs from human, mouse, fly, frog, and 
fish. Conserved residues are boxed in blue. Residues with 100% identity are highlighted 
in red with white text, and residues conserved in 70% of sequences are in red text. 
Notable regions included: Repeat 1 (R1) and Repeat 2 (R2) as previously identified 
(Gandre-Babbe and van der Bliek, 2008), an additional conserved region (R3), the coiled-
coil domain (CC) and the transmembrane segment (TM). The Mff sequences used in this 
alignment are (RefSeq): Homo sapiens mitochondrial fission factor isoform b 
(NP_001263991.1), Mus musculus mitochondrial fission factor isoform 1, NP_083685.2, 
Danio rerio mitochondrial fission factor homolog A, (NP_001018402.2), Xenopus laevis 
mitochondrial fission factor homolog B, (NP_001085443.1), and Drosophila 
melanogaster transport and golgi organization 11, isoform A (NP_726111.1). Alignments 
were performed with MultAlin (Corpet, 1988) and formatted with ESPript (Robert and 
Gouet, 2014).  
(B) Disordered regions in Mff. DisMeta, the Disorder Prediction MetaServer (Huang et 
al., 2014), was used to predict disordered regions in mouse Mff isoform 1. The consensus 
among 8 different predictors is plotted against each residue. A consensus above 50% of 
these predictors (dotted line) is indicative of disorder. The diagram of mouse Mff isoform 
1 is aligned with the plot. 
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Figure 2.S2. Yeast two-hybrid assay controls. 
(A) Auto-activation of Mff lacking the transmembrane region. Mouse Mff isoforms 1, 3, 
and 4 with the transmembrane domain deleted (ΔTM) were expressed from the pGBDU 
vector as BD fusion proteins and tested against Drp1 expressed from the pGAD vector as 
AD fusion proteins. Growth on adenine-deficient plates, but not against AD or BD only, 
indicates an interaction. The growth of the Mff constructs against AD only on adenine-
deficient plates (white asterisks) indicates auto-activation, making results with these 
constructs uninformative. (B) Diploid selection growths for the adenine-deficient plates 
in Figure 2.1E. (C) Lack of interaction between dynamin 2 and Mff. Mouse Dynamin 2, 
Drp1, MiD51, and Mff isoform 4 with the transmembrane domain deleted (Mff4ΔCC) 
were expressed as BD fusion proteins and tested against Dynamin 2 expressed as an AD 
fusion protein. Dynamin 2 interacted with itself, but did not interact with Drp1, MiD51, 
or Mff4ΔCC. (D) Diploid selection plates for the adenine-deficient plates in Figure 2.3A. 
(E) Diploid selection plates for the adenine-deficient plates in Figure 2.3B. 
 
Figure 2.S3. Phosphomimetic Drp1 does not interact with Mff61. 
(A) GST pull-down assays for purified recombinant Drp1ΔIB, Drp1 (full-length), Drp1 
S579D (full-length), and Drp1 S579E (full-length) versus purified recombinant Mff61-
GST (Mff fragment 1-61 fused C-terminally to GST) or T7-GST (T7tag-fused to GST). 
Shown are Coomassie-stained bands of either the input protein (lanes 1-4) or eluates from 
the pull-downs (lanes 5-12) following separation by SDS-PAGE. In lanes 5-12, the 
bottom row shows the isolated GST fusion proteins. The top row depicts the co-
immunoprecipitated proteins.  
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ABSTRACT 
 
DNM1L encodes dynamin-related protein (DLP1/DRP1), a key component of the 
mitochondrial fission machinery that is essential to proper functioning of the mammalian 
brain. Two previously reported probands with de novo missense mutations in DNM1L 
presented in the first year of life with severe encephalopathy and refractory epilepsy, one 
with death in the first 2 months of life. We report identical novel missense mutations in 
DNM1L in two unrelated probands who experienced essentially normal development for 
several years before presenting with refractory focal status epilepticus leading to 
subsequent neurological disability. We expand the phenotype of DNM1L-related 
mitochondrial fission defects, reveal common unique clinical characteristics and imaging 
findings, and compare the cellular impact of this novel mutation to the previously 
reported A395D lethal variant. We demonstrate that our R403C mutation generates a 
dominant-negative variant that reduces the oligomerization, mitochondrial fission 
activity, and mitochondrial recruitment of DRP1, but to a lesser extent compared to 
A395D. These observations suggest a common pathogenic mechanism for DNM1L 
mutations and are consistent with the less severe phenotype seen in individuals with 
R403C. 
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INTRODUCTION 
 
Mitochondria are essential for proper cellular function. Classically, 
“mitochondrial disease” implies a primary defect in a nuclear- or mitochondrial-encoded 
gene, whose disrupted protein product precludes adequate oxidative phosphorylation, and 
thus energy production in cells.1 Mitochondrial disease can present with a variety of 
disparate phenotypic features affecting multiple organ systems and may include 
developmental delay and regression, which can worsen with intercurrent illness, as well 
as myopathy, seizures, and other findings.1 Recently, with the advent of clinical whole 
exome sequencing, the list of conditions associated with mitochondrial dysfunction has 
greatly expanded and the term mitochondrial disease has been used more broadly. One 
group of conditions that has emerged involves disrupted mitochondrial dynamics.2 
 
Mitochondrial dynamics, consisting of fusion and fission, is an important 
regulator of mitochondrial function. Dynamin-related protein 1 (DRP1), or dynamin-like 
protein 1 (DLP1), encoded by DNML1,3 is the central molecular player that mediates 
mitochondrial fission. It is produced in the cytosol but can be recruited to the 
mitochondrial surface by receptors located on the outer membrane. There are currently 
four known DRP1 receptors: FIS1, MFF, MID49, and MID51.4 MFF appears to be the 
major DRP1 receptor, because removal of MFF causes the greatest defect in 
mitochondrial fission.5,6 Once recruited to mitochondria, DRP1 assembles into an 
oligomeric ring that drives constriction and scission of the mitochondrial tubule.7,8 DRP1 
has also been shown to be important for peroxisomal division.9 
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DRP1 belongs to the GTP-hydrolyzing dynamin superfamily of mechanoenzymes 
whose activity is regulated by self-assembly via a stalk domain with multiple interacting 
regions (classically referred to as the middle domain).10,11 DRP1 initially forms dimers 
that are stabilized by stalk-stalk interactions. Via a separate set of stalk-stalk interactions, 
these dimers then build higher order assemblies that form rings wrapping around the 
mitochondrial tubule. These rings are thought to constrict the diameter of the 
mitochondrial tubule and facilitate close lipid membrane interactions that are needed for 
scission.7,8 DRP1 self-assembly is also important because it stimulates GTP hydrolysis, 
which is necessary for scission. Finally, self-assembly facilitates DRP1 recruitment to the 
mitochondrial surface, because the major DRP1 receptor, MFF, only binds stably to 
oligomerized DRP1.12 
 
As a key component of mitochondrial fission, DRP1 is essential for proper 
mitochondrial function and furthermore, is critically important in the proper functioning 
of the mammalian brain and for survival in general. Constitutive homozygous Dnm1l 
knockout mice die during embryogenesis, and conditional Dnm1l ablation in mouse brain 
leads to developmental defects, both of which are associated with impaired mitochondrial 
fission.13,14 In humans, two probands with distinct de novo missense mutations in DNM1L 
have been reported in the literature. One presented in the first days of life with severe 
neonatal encephalopathy, microcephaly, abnormal brain development in the form of 
dysmyelination and altered gyral pattern, and optic atrophy. She died at 37 days of age 
after attaining no developmental milestones.15 She was found to have a de novo missense 
mutation in the middle domain of DRP1 (p.A395D), resulting in abnormal mitochondrial 
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and peroxisomal fission. The second proband presented at 6 months of age with global 
developmental delay, developed refractory epilepsy at one year of age with multiple 
subsequent episodes of status epilepticus, and remains profoundly globally 
developmentally delayed. He harbored a de novo missense change in the middle domain 
of DRP1 (p.G362D), again causing abnormal mitochondrial fission.16 In addition, two 
abstracts have reported additional individuals with DNM1L variants or mutations. The 
first reported two siblings with an autosomal recessive disorder due to compound 
heterozygous truncating mutations, both of whom died within the first month of life 
(Yoon et al., 2014, Neuromuscular disorders, abstract), and the second reported two 
unrelated individuals with distinct de novo missense changes in DNM1L and global 
developmental delay (L. Roback et al., 2015, American Society of Human Genetics, 
abstract).   
 
Here, we report identical, novel, de novo, heterozygous missense mutations in 
DNM1L [c.1207C>T (p.R403C)] in two unrelated individuals who share a remarkably 
similar phenotype that is delayed in onset compared to the previously reported cases. 
Despite the later onset, the course remains quite devastating. Both young boys had 
undergone a period of essentially normal development but then presented acutely in 
childhood with status epilepticus after minor metabolic insults and had variably 
progressive, yet remarkably similar courses involving refractory epilepsy, 
encephalopathy, developmental regression, myoclonus, and characteristic MRI findings. 
Through functional studies, we demonstrate that this mutation impacts a critical amino 
acid residue within the middle domain of DRP1 and exhibits a dominant negative effect 
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involving decreased recruitment of DRP1 to mitochondria, decreased DRP1 
oligomerization, and impaired mitochondrial fission, though not as marked as the 
previously reported A395D lethal variant.  Based on these investigations, the R403C 
mutation appears to be less severe and better tolerated at the phenotypic and cellular 
level, expanding the clinical presentation of disease associated with DNM1L-related 
mitochondrial fission defects.  
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MATERIALS AND METHODS 
 
Appropriate informed consent was obtained from human subjects. 
 
Exome Sequencing and Variant Filtering 
Clinical exome sequencing, including variant filtering, was performed by Baylor Miraca 
Genetics laboratories. 
 
Cloning 
Isoform b of mouse dynamin-like protein 1 isoform b (699 amino acids, NCBI 
NP_001021118.1) was used. DRP1 mutants A395D and R403C were generated by 
overlapping PCR mutagenesis and verified by sequencing. 
 
Cell lines and cell culture 
Cell lines were cultured in DMEM containing 10% fetal bovine serum, 100 I.U./ml 
streptomycin and 100 µg/ml penicillin. Drp1-null mouse cell lines were a generous gift 
from Katsuyoshi Mihara (Kyushu University, Fukuoka, Japan). Mff-null mouse cell lines 
were as previously described.5 Wild-type and Drp1-null MEF cell lines stably expressing 
mouse DRP1 and DRP1 mutants were generated by retroviral transduction of pQCXIP-
based (Clontech, Mountain View, CA) vectors with DRP1 cloned into the BamHI/EcoRI 
sites with a Kozak sequence. Transduced cells were selected in 0.5 µg/mL puromycin.  
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Immunostaining and imaging 
Antibodies to DRP1 (mouse anti-DLP1, BD Biosciences, San Diego, CA) and TOM20 
(rabbit anti-TOM20, Santa Cruz Biotechnology, Santa Cruz, CA) were used for 
immunostaining. Cells were grown in LabTek chambered glass slides (Nunc, Rochester, 
NY), then fixed in pre-warmed 4% formaldehyde for 10 minutes at 37°C, permeabilized 
in 0.1% Triton X-100, and incubated with antibodies in 5% fetal calf serum. For cytosol 
clearing of soluble DRP1, cells were permeabilized with 0.005% digitonin in buffer 
containing 20 mM HEPES, pH 7.3, 110 mM potassium acetate, 2 mM magnesium 
acetate, 0.5 mM ethylene glycol tetraacetic acid (EGTA), 220 mM mannitol, 70 mM 
sucrose, and 2 mM fresh dithiothreitol for 90 seconds at room temperature, then fixed and 
immunostained as above. Scoring of mitochondrial morphology was performed blind to 
genotype in triplicates of 100 cells. Imaging was performed with a Plan-Apochromat 
63x/1.4 oil objective on a Zeiss LSM 710 confocal microscope driven by Zen 2009 
software (Carl Zeiss, Jena, Germany). Images were cropped, globally adjusted for 
contrast and brightness, and median filtered using ImageJ (National Institutes of Health, 
Bethesda, MD).  
 
Yeast Two-Hybrid Assay 
DRP1 and DRP1 mutants were cloned into either the pGAD-C1 or pGBDU-C1 vectors 
and transformed into PJ69-4α and PJ69-4a yeast strains, respectively. Transformants 
were selected with leucine- and uracil-deficient plates, respectively, and haploid 
combinations for interaction testing were mated by spotting on YPD plus adenine plates, 
at 30°C. Diploids were selected by replica-plating onto leucine- and uracil-deficient 
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plates (labeled as +Adenine) at room temperature, and interactions were assayed 
following replica-plating on leucine-, uracil- and adenine-deficient plates (labeled as -
Adenine), at room temperature. Growth on adenine-deficient plates indicates a positive 
interaction, and interaction tests were performed at least three times.  
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RESULTS 
 
Exome sequencing reveals identical de novo missense DNM1L mutations in two 
unrelated, previously healthy children with sudden-onset epileptic encephalopathy  
Proband 1 was a previously healthy 4 year old male who presented with partial 
status epilepticus characterized by right hemibody clonus and impaired consciousness 
two weeks following his Diptheria, Tetanus, and Pertussis (DTaP) booster. The family 
denied any other illness or trauma in the weeks prior to presentation. Video 
electroencephalogram on admission revealed diffuse slowing with left central spikes time 
locked to right hand clonus, and magnetic resonance imaging (MRI) demonstrated 
curvilinear diffusion changes in the left thalamus (Figure 3.1A, arrow). MR angiogram 
was normal. He failed aggressive treatment with multiple antiepileptic drugs, ultimately 
being placed in pharmacologic coma with pentobarbital titrated to burst suppression for 5 
days. Following resolution of his status epilepticus he had expressive and receptive 
dysphasia, difficulty ambulating without maximum assistance, and decline in cognitive 
level to that of a toddler. Although his seizures improved on a regimen of phenytoin, 
levetiracetam, lacosamide, and clonazepam, he was readmitted 6 months after initial 
discharge with epilepsia partialis continua, which resolved over several days.  
 
His evaluation was extensive and included normal electrolytes, lactate, pyruvate, 
plasma amino acids, urine organic acids, acylcarnitine profile, very long chain fatty acids 
and ammonia. Cerebrospinal fluid cell count, protein, glucose, culture, HSV PCR and 
encephalitis panels were normal. Autoimmune testing for anti-NMDA, anti-GAD, anti-
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thyroglobulin and ANA was negative. Enzyme testing of palmitoyl-protein thioesterase 1 
and tripeptidyl peptidase 1 was normal. Mutation analysis for MELAS (MIM# 540000) 
and DNA sequencing of POLG (MIM#174763) were negative. Muscle biopsy was 
normal. Whole exome sequencing revealed a heterozygous de novo variant of unknown 
significance in DNM1L [c.1207C>T (p.R403C)]. 
 
At 8 years of age, seizures continue to occur on average 1-3 times per month 
without subsequent hospitalizations. He can ambulate short distances without assistance, 
but requires a wheelchair for longer distance. He has slow processing, inattention, 
cognitive delay, and intermittent aggressive behavior. He is able to speak, but has 
dysphasia. Follow-up MRI demonstrates mild diffuse cerebral atrophy, which is marked 
in the bilateral hippocampi (Figure 3.1B, C). 
 
Proband 2 was a previously healthy typically developing 5 year old male, except 
for mild expressive speech delay and dysarthria, who presented suddenly with focal 
status epilepticus and encephalopathy after minor head trauma involving a collision with 
another child without loss of consciousness and in the setting of a normal head CT. He 
had had a viral illness the week prior to presentation, during which he reportedly 
experienced increased clumsiness and subtle changes in behavior. Prior to that, he had 
tolerated routine childhood illnesses well. Initial electroencephalogram showed diffuse 
cerebral disturbance with widespread epileptiform activity maximal over the right fronto-
temporal region, correlating with his clinical presentation of status epilepticus involving 
the left side of his body. His status epilepticus was refractory to multiple therapies, 
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requiring several anti-epileptic medications, steroids, pharmacologic coma with 
pentobarbital, intravenous immune globulin (IVIg), ketogenic diet, and plasmapheresis 
prior to resolution. He experienced significant developmental regression and developed 
sustained myoclonus. He briefly recovered some function, including walking and 
speaking a few words initially. However, a few months later he presented again in 
refractory status epilepticus and has not recovered as well. Currently, at age 7, he has 
profound global developmental delay and remains hypertonic, hyperreflexic with 
myoclonus, tracheostomy and G-tube dependent, and wheelchair bound. 
 
Initial magnetic resonance imaging revealed a non-specific T2 hyperintensity in 
the right thalamus (Figure 3.1D, arrow) with follow up imaging showing similar T2 
hyperintensities in the right putamen and right frontal lobe (data not shown). Serial 
magnetic resonance imaging also revealed progressive global cerebral volume loss, 
particularly involving the right posterior putamen and bilateral hippocampi, with left 
greater than the right (Figures 3.1E,F). Magnetic resonance angiogram was normal. 
Magnetic resonance spectroscopy revealed decreased N-acetyl aspartate consistent with 
neuroaxonal loss or dysfunction, as well as elevated lactate, which can be seen in status 
epilepticus and in disorders involving mitochondrial dysfunction.  An elevated 
glutamate/glutamine (Glx) peak was also observed, the significance of which is unclear, 
though it may be related to seizure activity.  EEGs during his two hospital admissions 
continued to show intermittent focal status epilepticus mainly over the right hemisphere, 
sometimes associated with clinical seizure activity and sometimes subclinically. His EEG 
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progressed to showing bilateral background slowing with rhythmic slowing over the right 
hemisphere, consistent with a diffuse encephalopathy and focal seizure disorder.  
 
Extensive neurologic, infectious, rheumatologic, and biochemical genetics 
evaluations were mostly negative. Notably, lactate and amino acids in plasma and in 
cerebrospinal fluid were normal, as were analysis of very long chain fatty acids and two 
separate analyses of urine organic acids. He was found on SNP array to harbor an 
interstitial duplication on Xp21.3p21.2 involving the IL1RAPL1 gene (MIM#300206), 
which was inherited from his unaffected mother and is thought to be non-contributory. A 
forty-gene childhood-onset epilepsy panel, which includes among others the neuronal 
ceroid lipofuscinosis genes, MECP2 (MIM#300005), and POLG (MIM#174763), was 
negative.  
 
Whole exome sequencing, including mitochondrial sequencing, was performed. 
As an aside, he carries two likely tolerated/benign missense variants in ALDH5A1 
(MIM#610045), which is the causative gene for the autosomal recessive condition 
succinic semialdehyde dehydrogenase (SSADH) deficiency (MIM#271980). However, 
the diagnosis of SSADH deficiency can be ruled out because he lacks the ubiquitous 
gamma hydroxybutyric aciduria on repeated urine organic acid analyses and has normal 
levels of free and total gamma-aminobutyric acid (GABA) in cerebrospinal fluid.  
Ultimately, the proband was found to have a likely causative de novo heterozygous 
variant of unknown clinical significance in the DNM1L gene (MIM#603850), which 
encodes DRP1. The novel heterozygous missense change [c.1207C>T (p.R403C)] has 
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not been reported previously in diseased or healthy individuals and is predicted to be not 
tolerated and damaging by SIFT and Polyphen-2, respectively.  
 
Functional characterization of R403C in mouse embryonic fibroblasts reveals a 
dominant negative mechanism and impaired mitochondrial fission 
To determine whether the R403C mutation affects DRP1 function, we examined 
the effect of Drp1R403C in mouse embryonic fibroblasts (MEFs), where both wild-type 
and Drp1 mutant cells are available. In wild-type MEFs under basal conditions, 
mitochondria exist as a population of short and/or fragmented tubules (Figure 3.2B, C). 
In contrast, Drp1-null cells, due to unopposed fusion, have highly elongated and 
interconnected mitochondria (Figure 3.2A, C). Expression of wild-type Drp1 in these 
mutant cells restores fission, resulting in shorter mitochondrial tubules, whereas 
expression of Drp1A395D fails to rescue fission (Figure 3.2A, C). Expression of Drp1R403C 
only partially rescues fission in Drp1-null cells, resulting in an intermediate phenotype. 
The R403C mutation therefore impairs DRP1 function in MEFs, but not as severely as 
the A395D mutation. 
 
Because the R403C mutation was found to be heterozygous in the patients, we 
sought to determine whether Drp1R403C has a dominant-negative effect that can interfere 
with the function of wild-type DRP1 within the same cell. We expressed the mutant in 
wild-type MEFs containing endogenous DRP1. Indeed, we find that expression of 
Drp1R403C interferes with fission activity, resulting in mitochondrial elongation compared 
to control cells or cells expressing wild-type Drp1 (Figure 3.2B, C). Consistent with the 
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above results, we also find that expression of Drp1A395D has an even more severe 
dominant-negative effect, resulting in a higher proportion of cells with elongated 
mitochondria.  
 
R403C reduces DRP1 recruitment to mitochondria and self-assembly  
We wondered whether recruitment of DRP1 to mitochondria might be affected by 
the R403C mutation. To test this idea, we expressed wild-type Drp1, Drp1A395D, and 
Drp1R403C in Drp1-null cells and examined their co-localization with mitochondria 
(Figure 3.3A). For immunostaining of DRP1, we treated the cells with digitonin to 
remove cytosolic DRP1 before immunostaining. This treatment fragments mitochondria, 
but allows clear visualization of DRP1 puncta on mitochondria without interference from 
cytosolic DRP1 signals. For reference, we examined DRP1 localization in a cell line 
devoid of a major receptor, MFF, and found that DRP1 co-localization with mitochondria 
is much reduced compared to wild-type MEFs. In Drp1-null cells, we find that expressed 
wild-type DRP1 co-localizes with mitochondria, whereas expressed DRP1R403C and 
DRP1A395D show reduced signals, indicating loss of recruitment (Figure 3.3A).  
 
To examine whether expression of the mutants disrupts localization of 
endogenous Drp1, we expressed Drp1A395D and Drp1R403C in wild-type cells (Figure 
3.3B). We find that both mutants reduce the amount of DRP1 co-localizing with 
mitochondria, suggesting that the mutants dominantly interfere with recruitment of 
endogenous DRP1 to mitochondria. 
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In previous work, we showed that DRP1 recruitment by the major receptor MFF 
is dependent on the ability of DRP1 to assemble.12 We therefore tested whether DRP1 
assembly is affected by the R403C mutation in a yeast two-hybrid interaction assay 
(Figure 3.4A). Wild-type DRP1 interacts with wild-type DRP1, as indicated by growth of 
AD-DRP1 against BD-DRP1, whereas DRP1A395D fails to interact with wild-type DRP1 
(Figure 3.4A), indicating loss of higher order oligomer formation between the two. 
DRP1R403C weakly interacts with wild-type DRP1, suggesting that the R403C mutation 
affects DRP1 oligomerization but not to the extent of the A395D mutation (Figure 3.4A). 
Both A395 and R403 reside in a region of DRP1 thought to be important for mediating 
the dimer-to-dimer interactions required for assembly into oligomeric rings17 (Figure 
3.4B). In dynamin, the homologous residue of DRP1 R403 is R399, which has been 
demonstrated to be critical for higher order oligomerization.18 The crystal structure of the 
dynamin tetramer shows that the R399 residue from one dimer forms polar interactions 
with glutamate residues on adjacent dimers, helping to link one dimer to the next to form 
tetramers19 (Figure 3.4C). 
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DISCUSSION 
 
Our results indicate that the R403C mutation is a dominant-negative allele that is 
defective in oligomerization, recruitment to mitochondria, and mitochondrial fission 
activity. Each of these deficits is also present, and more severe, in the lethal A395D 
mutation, discovered in an individual who presented with abnormal brain development, 
encephalopathy, and lactic acidosis.15 The milder clinical phenotype of the R403C 
mutation is consistent with its milder defects in DRP1 function, compared to the original 
A395D mutation. 
 
Interestingly, the higher order oligomerization of DRP1 dimers appears to be critical for 
recruitment by MFF, the major DRP1 receptor on the mitochondrial surface.12 In a screen 
for DRP1 mutants that fail to bind MFF, it was found that mutations impairing DRP1 
self-assembly secondarily reduce binding to MFF, whereas binding to the alternative 
receptors MID49 and MID51 is less affected. Consistent with these findings, the R403C 
mutant shows reduced self-assembly and impaired recruitment to the mitochondrial 
surface. Because all the reported heterozygous DNM1L mutations15,16 localize to the stalk 
domain and appear to act as dominant-negative alleles, the impaired DRP1 self-assembly 
mechanism shown here may be a major pathogenic mode affecting DRP1 function. Self-
assembly is critical for DRP1 function, because it enhances GTP hydrolysis activity and 
facilitates DRP1 recruitment via MFF. Importantly, the A395D and R403C mutations 
impair higher order assembly but allow dimer formation. Therefore, they act as 
dominant-negative alleles, allowing heterozygous mutations to greatly impact neuronal 
function. 
89 
 
 
We found the R403C mutation in two unrelated individuals with strikingly similar 
clinical features. Both had been developing essentially normally for 4-5 years before 
presenting with sudden-onset refractory status epilepticus after distinct minor metabolic 
insults. Both subsequently had a devastating course with refractory epilepsy, myoclonus, 
brain atrophy on MRI, and regression, resulting in profound global developmental delay.  
The predicted damaging nature of the change, which is corroborated by the functional 
studies herein, as well as the strikingly similar phenotypes observed, make this the likely 
cause of the probands’ clinical findings.  Of the individuals reported to have DNM1L-
related mitochondrial fission defects, all except for one sibship have had heterozygous de 
novo missense mutations impacting the middle domain of DRP1, and both the R403C 
(reported here) and A395D15 mutations exhibit a common dominant-negative mutation 
mechanism, with the A395D mutation exhibiting a more severe cellular and clinical 
phenotype compared to R403C.  
 
The previously reported individuals with DNM1L-associated mitochondrial fission 
defects had more severe phenotypes than the two probands reported here with regard to 
age of onset and severity. Our report therefore expands the phenotypic spectrum of this 
group of disorders. The patient with the A395D mutation15 presented in the first days of 
life with neonatal encephalopathy and died at 37 days of age after attaining no 
developmental milestones.15 The patient with the G362D mutation16 presented at 6 
months of age with global developmental delay and went on to develop refractory 
epilepsy with repeated bouts of status epilepticus. Finally, the sibship containing 
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compound heterozygous truncating mutations, which would predict little to no DRP1 
function, died at 5 days and 3 weeks of life (Yoon et al., 2014, Neuromuscular disorders, 
abstract). In contrast, the two unrelated probands reported here had periods of essentially 
normal development until 4-5 years of age when they presented with sudden-onset status 
epilepticus and subsequent developmental regression and encephalopathy. In all cases, 
the developmental delay was ultimately profound. The previously reported individuals 
were not reported to exhibit developmental regression, unlike the probands reported here.  
 
Furthermore, all three living probands have experienced one or more bouts of refractory 
status epilepticus; however, only two of the three individuals (those reported here) were 
thought to exhibit similar findings on brain MRI, including diffuse cerebral atrophy 
involving the hippocampi and non-specific thalamic hyperintensities. Notably, proband 2 
was on steroids during his course, which could have contributed to the cerebral atrophy, 
but the same was not the case for proband 1, supporting the idea that atrophy is part of 
the disease process rather than being iatrogenic. 
 
Importantly, with respect to laboratory work up, the initially reported A395D mutation 
exhibited persistently elevated lactate and alanine levels in blood and CSF, and elevated 
plasma very long chain fatty acids due to the defects in mitochondrial and peroxisomal 
fission.15 However, none of the three living probands exhibited these laboratory findings 
on routine biochemical screening tests, suggesting a less severe defect. Therefore, routine 
biochemical screening tests will not necessarily identify individuals with these disorders. 
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Because of this and the extremely rare nature of these conditions, whole exome 
sequencing is currently the most efficient and effective way to diagnose these conditions.  
 
Another provocative similarity between the two cases reported here, particularly with 
respect to presentation of more classic mitochondrial disorders, is that there is often a 
preceding illness or other metabolic insult prior to initial presentation and/or prior to 
episodes of developmental regression or worsening of seizures. Interestingly, each 
individual reported here experienced a minor metabolic insult prior to initial presentation. 
Proband one received a DTaP booster a few weeks prior to his presentation, and proband 
two had a viral illness the week prior to his presentation. These remain interesting 
correlations at this point, and there is no way to prove causality.  Intriguingly however, a 
similar correlation exists in three individuals with mitochondrial fission defects resulting 
from homozygous truncating mutations in STAT2, a novel regulator of DRP1.20 All three 
presented shortly after receiving the measles, mumps, rubella (MMR) vaccine with 
febrile illness, and one of them progressed to having opsoclonus-myoclonus, refractory 
epilepsy, spasticity, and cortical vision impairment.20   
 
Finally, it is worth noting that several members of the dynamin family of large 
GTPases,10,11 of which Drp1 is a member, have now been implicated in a range of 
neurologic disorders. Recently, mutations in dynamin 1 (DNM1), a GTPase involved in 
synaptic vesicle recycling and endocytosis, have been found in seven individuals with 
epileptic encephalopathy.21,22 Mutations in dynamin2 (DNM2), also involved in 
endocytosis, are responsible for some forms of Charcot-Marie-Tooth,23 centronuclear 
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myopathy,24 and a lethal congenital syndrome.25 Mutations in atlastin-1 (ATL1), involved 
in homotypic fusion of the endoplasmic reticulum, have been implicated in some forms 
of spastic paraplegia26 and hereditary sensory neuropathy.27 Furthermore, mutations in 
the dynamin family genes MFN2 and OPA1, involved in mitochondrial fusion, also cause 
neurological defects in humans.28,29 The latter observation, along with the DNM1L 
mutation reported here, suggests that defects in either mitochondrial fusion or fission can 
cause neurological disease. Indeed, more common late-onset neurodegenerative 
conditions, like Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and 
amyotrophic lateral sclerosis (ALS), have been shown to exhibit abnormal mitochondrial 
dynamics.29 These observations further support mitochondrial fission and fusion defects 
as a pathological mechanism causing significant neurocognitive compromise, and thus 
morbidity and mortality, for individuals of all ages with both rare and common diseases, 
and sets the stage for the design of novel therapeutic strategies aimed at restoring the 
disrupted balance of mitochondrial dynamics. 
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FIGURE LEGENDS 
 
Figure 3.1.  Magnetic resonance imaging of brains from probands 1 and 2.  
(A) Axial diffusion-weighted magnetic resonance image with white arrow showing 
curvilinear intensity in the left thalamus in proband 1. (B,C) Coronal magnetic resonance 
images obtained from proband 1 at (B) initial presentation and (C) one month following 
resolution of status epilepticus show progressive atrophy of the brain, most marked in the 
hippocampi. (D) Axial T2 FLAIR magnetic resonance image with white arrow showing 
hyperintensity in the right central thalamus in proband 2, which was faintly hyperintense 
on diffusion-weighted imaging as well. (E,F) Coronal magnetic resonance images 
obtained from proband 2 at (E) initial presentation and (F) one year following resolution 
of status epilepticus show progressive atrophy of the brain, particularly involving the 
right posterior putamen and bilateral hippocampi (left greater than right). 
 
Figure 3.2. Mutants R403C and A395D have dominant-negative effects on mitochondrial 
fission. 
 (A) Fission activity upon expression in Drp1-null MEFs. Drp1-null MEFs expressing 
wild-type Drp1, Drp1A395D, and Drp1R403C were fixed and immunostained against the 
outer membrane protein TOM20 to visualize mitochondrial morphology. (B) Same as (A) 
except that wildtype MEFs were used.  (E) Quantitation of mitochondrial morphology. 
Cells were scored into three categories of mitochondrial profiles: short, long tubular, or 
elongated and/or collapsed mitochondrial tubules. Quantitation was done in triplicate, 
with 100 cells scored per experiment. Error bars, SEM.  
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Figure 3.3. Recruitment to mitochondria is impaired in the A395D and R403C mutants.  
(A) Analysis of Drp1 alleles in Drp1-null MEFs. Cells expressing the indicated alleles 
were briefly permeabilized with digitonin to clear cytosolic DRP1 before fixation. This 
resulted in mitochondrial fragmentation, but DRP1 puncta remained on mitochondria for 
visualization by immunostaining with an antibody against DRP1 (DRP1, green). 
Mitochondria were visualized by immunostaining against TOM20 (Mito, red). The DRP1 
signal, mitochondrial signal, and merged signals are shown. Inset squares are 
magnifications of the boxed region in the main image. In the first column, Mff-null MEFs 
are shown as a reference for defective DRP1 recruitment to mitochondria. (B) Same as 
(A), except that wildtype MEFs are used. 
 
Figure 3.4. Assembly defect of DRP1 mutants 
(A) DRP1 oligomerization assessed by the yeast two-hybrid assay. DRP1 and DRP1 
mutants expressed from the pGAD vector as GAL4 activation domain (AD) fusion 
proteins were tested against DRP1 expressed from the pGBDU vector as a GAL4 DNA-
binding domain (BD) fusion proteins. Growth on adenine-deficient plates indicates an 
interaction. (B) Ribbon diagram of DRP1 (PDB file: 4BEJ) depicting the location of the 
R403 and A395 residues. Circled is the region (Interface 3) predicted to mediate dimer-
to-dimer interactions during DRP1 oligomerization. (C) Ribbon diagram of the dynamin 
tetramer (PBD file: 5A3F). The violet and green dynamin monomers compose the dimer 
on the left, and the gray and blue monomers compose the dimer on the right. The inset 
depicts interface 3 of the dimer:dimer interaction, with the green monomer of the left 
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dimer removed for clarity. The dynamin residues depicted are labeled on the left, next to 
the corresponding residues on DRP1. 
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Chapter 4 
 
 
Discussion 
 
My work can be distilled into the following findings:  
1. The N-terminal Mff motif and the Drp1 stalk domain form the core Drp1-Mff 
interaction unit. 
2. The Drp1 Insert B domain inhibits the interaction between Mff and Drp1.  
3. Drp1 mutants that disrupt self-assembly also disrupt stable binding to Mff, but 
not necessarily MiD51 or MiD49. 
4. Drp1 mutants that disrupt self-assembly are implicated in causing human 
disease 
From these findings and the supporting data, we propose a model in which the primary 
function of Mff is to recruit fission-competent species of Drp1 to mitochondria for 
productive assembly into oligomeric complexes, promoting mitochondrial fission. The 
requirement for Drp1 oligomerization in maintaining a stable Drp1-Mff interaction 
(Figure 4.1) acts as a functional test and filtering mechanism to selectively recruit active 
species of Drp1. We imagine that the purpose of this can be to facilitate efficient Drp1 
oligomerization or assembly following signals to induce fission (Chan et al., 2011). By 
ensuring that only oligomerization-competent Drp1 can stably occupy Mff foci, a block 
to ring assembly caused by accumulation of inactive Drp1 species is prevented, allowing 
timely mitochondrial fission to occur.  
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The MiD proteins do not seem to follow the same rules, as we observe they are 
not as strongly affected by the Drp1 oligomerization mutants we tested. This suggests a 
non-redundant role for MiD in Drp1 recruitment, and future studies aimed at uncovering 
the rules for their Drp1 recruitment mechanism will be informative (Otera et al., 2016). 
Though each species has been shown to be capable of recruiting Drp1 and mediating 
fission independently, it is tempting to speculate how the MiDs and Mff might cooperate 
to regulate mitochondrial morphology (Koirala et al., 2013; Palmer et al., 2013; Elgass et 
al., 2015; Otera et al., 2016). It has been suggested that MiD51 binding to Drp1 is more 
stable than that of Mff (Palmer et al., 2013). In Chapter 2 we propose that the MiDs 
might play a role in recruiting inactive species of Drp1 (Liu and Chan, 2015). If this is 
true, then this would have the effect of providing a local Drp1 reservoir that could be 
accessed by Mff following Drp1 activation by a cellular signal. As discussed in Chapter 
1, loss of MiD51 results in a reduction of mitochondrial fission, whereas overexpression 
of MiD51 leads to accumulation of Drp1, and a block of fission. To test whether MiD51 
can source Mff receptors with Drp1, we can induce fission in cells overexpressing 
MiD51, and examine whether fission is triggered in the presence and absence of Mff. If 
fission is achieved only in the presence of Mff, then this might support a model in which 
the MiDs recruits inactive species of Drp1 for Mff to later assemble. How this model 
reconciles with the observation that the MiDs can mediate some level of mitochondrial 
fission, which suggests that the MiDs can recruit active species as well, will be worth 
examining. 
Several interesting results were not included in Chapter 2 due to lack of 
supporting evidence. These results might eventually find their way to publication in a 
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journal, but in case time runs out, I will describe them here with hope that it will inspire 
additional work into clarifying the Drp1 recruitment model, or at the very least, inject 
some ideas into the discussion. As can be gleaned from careful examination of the 
figures, the oligomerization defects of Drp1 Mutant 10 in Chapter 2 are milder than that 
of Drp1 Mutants 16 and 17. Since the mutant shows loss of binding to Mff, one possible 
interpretation is that the residues composing the mutant (Y368 and E372) might also 
represent part of the Drp1 binding interface to Mff, and that its effects on oligomerization 
are a consequence of their proximity to the relevant loops. If confirmed, this knowledge 
might be useful in designing co-crystallization strategies for determining the structure of 
this complex. In addition to the stalk domain screen described in Chapter 2, a similar 
yeast two-hybrid screen was conducted on the Drp1 GTPase domain. Interestingly, 
although the Drp1 stalk domain is sufficient to bind Mff, we find that some GTPase 
mutants disrupt or weaken the Drp1-Mff interaction. Since the Insert B domain inhibits 
Drp1 binding to Mff, we tested the same mutants in the absence of Insert B, and found 
that Drp1-Mff is restored. One idea to explore from this finding is a possible interaction 
between the GTPase domain and Insert B domain, perhaps between adjacent monomers. I 
find it likely that nucleotide occupancy plays a role in the conformational state of the 
Insert B domain, and vice versa. Perhaps most interestingly, we also found that mutations 
in the Switch 1 domain, such as the T59A mutation, disrupt Drp1 binding to MiD51 more 
strongly than it does to Mff, especially without the Insert B domain. We find this to be 
significant, because of all the mutants we have examined, it is the only class of mutants 
that affects binding to MiD51 more so than to Mff or Drp1. The mechanism behind this is 
unknown, but I suspect it figures prominently in describing how Drp1 recruits MiD51.  
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 Finally, it is becoming clear that mutations affecting Drp1 oligomerization have 
an impact on human health and disease. In addition to the discovery of the R403A 
mutation found in human patients discussed in Chapter 3, several other pathogenic stalk 
domain mutants of Drp1 have been recently described, raising the possibility that this 
might not be a rare occurrence (Chang et al., 2010; Chao et al., 2016; Fahrner et al., 
2016; Sheffer et al., 2016). Studies examining how these oligomerization defects 
contribute to the development of these neurological disorders will be of upmost 
importance.  
 
                               
Figure 4.1 
Mechanistic model of the Mff-Drp1 interaction. Drp1 (black crosses) exist in 
equilibrium as soluble dimers and tetramers in the cytosol. Mff (tethered to the outer 
mitochondrial membrane) can only effectively recruit Drp1 species that are able to 
oligomerize to form a stable interaction with the Mff dimer.  
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